Plant treatment products and related methods

By combining plant-based treatment components in plant-based treatment products with microbial fermentation products, the environmental and health hazards of synthetic chemicals are solved, achieving safe and effective crop protection and pesticide resistance management.

CN118947730APending Publication Date: 2024-11-15CYTOZYME LABORATORIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410987391.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2017-06-02
Filing Date
2018-06-01
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing crop protection products, such as herbicides and pesticides, are synthetic chemicals that are harmful to the environment and human health and lead to increased pesticide resistance in pests. Safe and effective alternatives are needed to reduce chemical use and lower the risk of pesticide resistance.

Method used

Plant-based treatment products, including mixtures of plant-based treatment components and microbial fermentation products such as pesticides, plant growth regulators, and microbial fermentation products such as lysates of Lactobacillus bacteria, are used to treat crops to enhance their health.

Benefits of technology

It provides safe protection for crops, reduces chemical residues, lowers the risk of pest resistance, and improves crop health indicators such as yield and overall health.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004957835080000571
    Figure BDA0004957835080000571
  • Figure BDA0004957835080000572
    Figure BDA0004957835080000572
  • Figure BDA0004957835080000573
    Figure BDA0004957835080000573
Patent Text Reader

Abstract

The plant treatment product comprises plant treatment components, and is preferably mixed with the microbial fermentation product. The microbial fermentation product includes a cellular material of a cultured microorganism and one or more anaerobic metabolites of the cultured microorganism. Preferably, the microbial fermentation product comprises a complete culture lysate of a microbial fermentation suspension culture, including a liquid fermentation medium component and a lysed microorganism. The plant treatment components of the product include one or more pesticides or plant growth regulators. The plant treatment product may be applied to a plant or seed or surroundings thereof to enhance the growth, health or productivity of the plant.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the Chinese invention patent application with the application date of June 1, 2018, the priority date of June 2, 2017, the application number 201880035892.5, and the invention name “Plant Treatment Products and Related Methods”. Technical Field

[0002] The present invention relates to plant management and, more particularly, to plant treatment products and methods of making and using the same. Background Art

[0003] Crop protection is an important part of crop management and may lead to reduced diseases and increased crop yields. However, the use of conventional synthetic crop protection products such as herbicides, insecticides, bactericides or fungicides creates many problems. These products are often non-specific and may disrupt the natural healthy biome of the crop. In addition, due to their synthetic nature, these products may be toxic to humans and animals and leave toxic residues in the crop or in the environment. The repeated use of synthetic chemicals with a specific single mode of action often leads to the development and / or selection of resistant organisms.

[0004] In addition, consumers around the world have become aware of the potential environmental and health issues associated with residual chemicals in food and groundwater and have begun to put pressure on growers to reduce the use of synthetic chemicals in food chain crop production. Thus, there are many shortcomings in the field of crop protection that can be addressed. For example, in one area, what is needed are new crop protection alternatives that, alone or in combination with reduced rates of synthetic chemicals, will meet consumer demands, reduce the risk of pest resistance, and produce healthier crops. Summary of the invention

[0005] Embodiments of the present disclosure solve one or more of the foregoing or other problems in the art through products and methods for treating, supplementing or protecting plants (especially crops). Specifically, embodiments of the present disclosure include plant treatment products and methods of making and / or using the same (e.g., to enhance the health of plants). Some embodiments relate to a plant treatment product comprising (i) one or more plant treatment (or crop protection) components and (optionally mixed with (ii) one or more microbial fermentation products or components). In some embodiments, one or more additional products or components may be included. Some embodiments relate to methods of making products. Some embodiments relate to methods of using products. For example, embodiments may include methods of treating plants or crops. Exemplary (crop treatment) methods may include the step of co-applying (or co-administering) the product or its components to the plant or crop.

[0006] Various exemplary plant treatment components may include at least one pesticide (e.g., one or more (synthetic) chemicals, molecules or compounds, or a mixture of two or more (synthetic) chemicals, molecules or compounds). The pesticide may be or include one or more of the following: (1) an insecticide (e.g., to control Lepidoptera, Hemiptera, Diptera, Coleoptera, etc.), (2) a non-insecticide pesticide (e.g., to control rodents, amphibians, etc.), (3) an antimicrobial (e.g., a fungicide, a bactericide, an antibiotic, an antiparasitic, an antiviral, etc.), (4) an herbicide (selective or non-selective), and (5) a nematicide. The plant treatment product or its plant treatment component may also or alternatively include at least one plant growth regulator (PGR) (e.g., one or more hormones, such as auxins, gibberellins, cytokinins, abscisic acid (ABA) and / or ethylene, or a mixture of two or more hormones). In some embodiments, the plant treatment product or its plant treatment component may include a fertilizer. In preferred embodiments, the plant treatment product or plant treatment component may be (substantially or completely) free of one or more fertilizers (eg urea and / or nitrogen-containing fertilizers).The plant treatment product or plant treatment component may be in substantially dry or liquid form.

[0007] Exemplary microbial fermentation products may include (1) cell material from one or more microorganisms and (2) one or more anaerobic metabolites of one or more microorganisms. Exemplarily, the cell material may include one or more non-living (e.g., lysed) microorganisms, preferably cellular (e.g., molecular and / or structural) components of prokaryotic bacteria. In some embodiments, metabolites are metabolites of the microorganisms (or produced by the microorganisms). In some embodiments, the one or more microorganisms may be or include bacteria, preferably species or strains of Lactobacillus (e.g., acidophilus, etc.), as described herein. In some embodiments, the one or more microorganisms may include one or more (additional) microorganisms (e.g., bacteria) species and / or strains (e.g., different from (first) Lactobacillus species or strains). Alternatively, or in addition, the cell material may include extracts of cell components or one or more fungi (e.g., yeast) and / or algae species or strains. In some embodiments, the fermentation product may include one or more components of (fermentation) culture medium. In some embodiments, the fermentation product may be or include microbial (liquid) fermentation culture.

[0008] Some embodiments can be substantially and / or completely free of one or more probiotics and / or live microorganisms.For example, in some embodiments, the microbial fermentation product can comprise the complete culture lysate of microbial suspension (fermentation) culture.The culture can be cracked, thereby substantially and / or completely free of probiotics and / or live microorganisms.Its culture and / or lysate can comprise the anaerobic metabolites of the microorganism of liquid culture medium, cracking and cracking.Described culture and / or its lysate can comprise one or more additives or culture medium components.

[0009] The plant treatment product or microbial fermentation product may include one or more additives (or additional components) selected from the following: (1) amino acids, (2) peptides, (3) hydrolyzed proteins, (4) organic acids and / or carboxylic acids, (5) carbohydrates, (6) plant extracts and / or seaweed extracts, (7) lignin sulfonates, (8) humic acid and / or fulvic acid, (9) major nutrients, secondary nutrients and / or micronutrients, (10) chelated minerals and / or complex minerals, (11) vitamins, (12) wetting agents, (13) dispersants, and (14) surfactants. Some embodiments may include a mixture of two or more of the foregoing. Some embodiments may include a mixture of amino acids, minerals, and organic acids. In some embodiments, the one or more additives may be included in the (active or living) culture or added to the lysate. In other embodiments, one or more additives may be added to the plant treatment product (or to a mixture of the microbial fermentation product and the plant treatment component).

[0010] In certain embodiments, the microbial fermentation product can be a liquid or suspension form. In certain embodiments, the microbial fermentation product can be dry, substantially dry, or partially dry form. For example, in at least one embodiment, the microbial fermentation product can be applied, bonded to a carrier or excipient or mixed with it. Illustratively, the carrier can include naturally occurring soil components, such as phyllosilicate or clay minerals.

[0011] At least one embodiment includes a method for producing a plant treatment product, the method comprising providing a plant treatment component and mixing the plant treatment component with a microbial fermentation product. An exemplary method for producing a plant treatment product comprises combining a substantially liquid microbial fermentation product with a plant treatment component, preferably in a ratio of about 1:1 to about 1:100, adding the fermentation product to the plant treatment component for combination, or combining the plant treatment component with the fermentation product to form a plant treatment product. One or more alternative or additional embodiments of producing a plant treatment product comprise combining a substantially dry fermentation product (e.g., a fermentation product combined with a carrier) with a plant treatment component, preferably in a ratio of about 1:1 to about 1:100, adding the fermentation product to the plant treatment component for combination, or combining the plant treatment component with the fermentation product to form a plant treatment product.

[0012] Some embodiments include methods for manufacturing plant treatment products. The method may include mixing plant treatment components with microbial fermentation products to form plant treatment products (or combination products). In certain embodiments, before product distribution, liquid plant treatment components are mixed with liquid microbial fermentation products in a tank or mixer. In one or more additional or alternative embodiments, liquid plant treatment components and liquid microbial fermentation products are prepared together. Other ingredients may be mixed with plant treatment components, microbial fermentation products, or their mixtures.

[0013] In some embodiments, the plant treatment product may include a kit or system including a plant treatment component and a microbial fermentation product. The kit or system may include instructions for mixing the plant treatment component with the microbial fermentation product for application to one or more plant or crop types. The kit or system may include instructions for applying the plant treatment component and the microbial fermentation product together to one or more plant or crop types.

[0014] Additional embodiments include methods of treating and / or enhancing the health of one or more plants or crops. The methods may include applying (i.e., dosing) or co-applying an effective amount of a plant treatment product (or a component thereof) to a plant, preferably to improve one or more health indicators of a plant or plant population (e.g., compared to a control group). The one or more health indicators may be selected from the group consisting of: wilting, coloration, yield, size and / or weight, lifespan and / or mortality, overall health and appearance, disease and / or disease effects (e.g., rot), and the like.

[0015] Alternatively, the method may comprise applying (or co-applying) an effective amount of a plant treatment product (or a component thereof) to seeds (e.g., a group of seeds intended for sowing), preferably so as to improve one or more health indicators of the germinated seeds and / or subsequently germinated plants or plant populations. The one or more health indicators may be selected from the group consisting of: stronger germination, wilting, coloration, yield, size and / or weight, lifespan and / or mortality, overall health and appearance, disease and / or disease effects (e.g., rot), etc.

[0016] The step of applying (or administering) can include spraying and / or distributing the plant treatment product (e.g., comprising plant treatment components and microbial fermentation products or mixtures thereof, individually) on the plant or near the plant, such as on the soil, so that the plant takes in an effective amount of the plant treatment product from the soil. The plant treatment components and microbial fermentation products can also be co-administered or co-applied (e.g., applied together, applied as a combination product, or applied separately). Soil treatment using the disclosed plant treatment product can be carried out before planting, before germination, after germination, and at any time during the life of the plant.

[0017] The present application further relates to the following embodiments:

[0018] 1. A plant treatment product comprising:

[0019] Pesticides, preferably selected from the group consisting of: fungicides; and

[0020] A bacterial fermentation product comprising a whole culture lysate of a suspension culture of Lactobacillus, the whole culture lysate comprising:

[0021] Fermentation medium;

[0022] lysed Lactobacillus bacteria cellular material; and

[0023] One or more anaerobic metabolites of Lactobacillus bacteria,

[0024] wherein the bacterial fermentation product is substantially free of live microorganisms, and

[0025] Wherein the plant treatment product is substantially free of one or more nitrogen-based fertilizers, preferably free of urea.

[0026] 2. The product according to embodiment 1, wherein the pesticide and the bacterial fermentation product are mixed together in liquid form.

[0027] 3. The product according to embodiment 2, further comprising one or more additives selected from the group consisting of amino acids, peptides, hydrolyzed proteins, organic acids, carboxylic acids, carbohydrates, plant extracts, lignin sulfonates, humic acid and / or fulvic acid, macronutrients, subnutrients, micronutrients, chelated minerals, complex minerals, vitamins, wetting agents, dispersants and surfactants.

[0028] 4. A plant treatment product comprising:

[0029] A plant treatment component, the plant treatment component comprising:

[0030] Pesticides; and / or

[0031] Plant growth regulators (PGRs); and

[0032] A microbial fermentation component, the microbial fermentation component comprising:

[0033] cellular material of one or more microorganisms, preferably one or more unicellular microorganisms, more preferably one or more bacteria; and

[0034] One or more anaerobic metabolic products of the one or more microorganisms.

[0035] 5. A plant treatment product comprising:

[0036] a plant treatment component selected from the group consisting of: a pesticide and a plant growth regulator (PGR); and

[0037] A microbial fermentation product, comprising:

[0038] cellular material of one or more microorganisms, preferably one or more unicellular microorganisms, more preferably one or more bacteria; and

[0039] One or more anaerobic metabolic products of the one or more microorganisms.

[0040] 6. The product according to embodiment 5, wherein at least one of the following:

[0041] The pesticide comprises one or more components selected from the group consisting of insecticides, non-insecticide pesticides, antimicrobials, herbicides, and nematicides; and

[0042] The plant growth regulator (PGR) comprises a hormone, preferably selected from the group consisting of auxins, gibberellins, cytokinins, abscisic acid (ABA) and ethylene.

[0043] 7. The product according to embodiment 6, wherein at least one of the following:

[0044] The antimicrobial agent is one or more of a fungicide, a bactericide, an antibiotic, an antiparasitic agent, or an antiviral agent; and

[0045] The herbicide is one or more of a selective herbicide and a non-selective herbicide.

[0046] 8. The product of embodiment 5, wherein the microbial fermentation product is substantially free of one or more living microorganisms.

[0047] 9. The product according to embodiment 5, wherein the product is substantially free of one or more fertilizers, preferably free of nitrogen-based fertilizers, more preferably free of urea.

[0048] 10. The product according to embodiment 5, wherein the microbial fermentation product comprises:

[0049] cellular material of bacteria of the genus Lactobacillus and optionally one or more additional microbial species and / or strains; and

[0050] One or more anaerobic metabolites of a bacterium of the genus Lactobacillus lactis and optionally one or more additional microbial species and / or strains.

[0051] 11. The product of embodiment 5, wherein the microbial fermentation product comprises a whole culture lysate of a microbial suspension culture, the lysate comprising a microbial suspension culture, the cellular material, and the one or more anaerobic metabolites.

[0052] 12. The product according to embodiment 5, further comprising one or more additives selected from the group consisting of: amino acids, peptides, hydrolyzed proteins, organic acids, carboxylic acids, carbohydrates, plant extracts (preferably seaweed extracts, the seaweed preferably comprising Ascophyllum nodosum), lignin sulfonates, humic acid, fulvic acid, major nutrients, secondary nutrients, micronutrients, chelated minerals, complex minerals, vitamins, wetting agents, dispersants and surfactants.

[0053] 13. The product according to embodiment 5, further comprising a mixture of amino acids, minerals and organic acids.

[0054] 14. A method of making a plant treatment product, the method comprising mixing a microbial fermentation product with a plant treatment component selected from the group consisting of: a pesticide and a plant growth regulator (PGR), the microbial fermentation product comprising:

[0055] cellular material of one or more microorganisms, preferably comprising one or more unicellular microorganisms; and

[0056] One or more anaerobic metabolic products of the one or more microorganisms.

[0057] 15. The method of embodiment 14, wherein the microbial fermentation product comprises a whole culture lysate of a Lactobacillus fermentation suspension culture and optionally one or more additional microbial species and / or strains, the lysate comprising:

[0058] cellular material of bacteria of the genus Lactobacillus and optionally one or more additional microbial species and / or strains; and

[0059] One or more anaerobic metabolites of a bacterium of the genus Lactobacillus lactis and optionally one or more additional microbial species and / or strains.

[0060] 16. A method of treating plants, comprising:

[0061] Apply to the plants:

[0062] a plant treatment component selected from the group consisting of: a pesticide and a plant growth regulator (PGR); and

[0063] A microbial fermentation product, comprising:

[0064] cellular material of one or more microorganisms, preferably comprising one or more unicellular microorganisms; and

[0065] One or more anaerobic metabolic products of the one or more microorganisms.

[0066] 17. A method for treating plants, seeds and / or soil, comprising:

[0067] applying to at least one of the plant, the seed or the soil:

[0068] Plant treatment components; and

[0069] A microbial fermentation product, comprising:

[0070] cellular material of one or more microorganisms, preferably one or more unicellular microorganisms, more preferably one or more bacteria; and

[0071] One or more anaerobic metabolic products of the one or more microorganisms.

[0072] 18. The method of embodiment 17, wherein:

[0073] The cellular material is of a particular species or bacterium of the genus Lactobacillus and optionally of one or more additional microbial species and / or strains; and

[0074] The one or more anaerobic metabolites are anaerobic metabolites of the specific species or strain of Lactobacillus and optionally the one or more additional microbial species and / or strains.

[0075] 19. The method of embodiment 17, wherein the plant treatment component and the microbial fermentation product are co-applied to at least one of the plant, the seed, or the soil.

[0076] Additional features and advantages of the exemplary embodiments of the present disclosure will be set forth in the following description and will become apparent in part from the description, or may be understood by practicing such exemplary embodiments. The features and advantages of these embodiments may be realized and obtained by the instruments and combinations specifically noted in the appended claims. These and other features will become more apparent from the following description and the appended claims, or may be understood by practicing these exemplary embodiments as described below. DETAILED DESCRIPTION

[0077] Before describing in detail various embodiments of the present disclosure, it should be understood that the present disclosure is not limited to the specific parameters and descriptions of the systems, methods and / or products of specific examples, and the systems, methods and / or products of one embodiment may be different from the next embodiment. It should also be understood that many (if not all) terms used herein are only used for the purpose of describing specific embodiments of the present disclosure, and are not necessarily intended to limit the scope of the present disclosure in any particular way. Therefore, although certain embodiments of the present disclosure will be described in detail with reference to specific configurations, parameters, features (e.g., ingredients, components, members, elements, parts and / or parts), etc., these descriptions are illustrative and should not be interpreted as limiting the scope of the present disclosure and / or the claimed invention. In addition, the terms used herein are for the purpose of describing the embodiments and are not necessarily intended to limit the scope of the present disclosure and / or the claimed invention.

[0078] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs.

[0079] Various aspects of the present disclosure, including systems, methods and / or products, may be described with reference to one or more embodiments that are exemplary or illustrative in nature. As used herein, the term "embodiment" means "serving as an example, instance, or illustration" and should not be interpreted as being more preferred or advantageous than other aspects disclosed herein. In addition, references to the embodiments are intended to provide illustrative examples and not to limit the scope of the invention, which is indicated by the appended claims rather than by their description. The terms "exemplary," "illustrative," and the like may be used interchangeably and / or refer to one or more embodiments.

[0080] As used throughout this disclosure, the words "can" and "may" are used in a permissive sense (i.e., meaning having the potential to), rather than a mandatory sense (i.e., meaning must). Additionally, the terms "including," "having," "involving," "containing," "characterized by," variations thereof (e.g., "includes," "has," and "involves," "contains," etc.), and similar terms used herein (including the claims) shall be inclusive and / or open-ended and shall have the same meaning as "comprising" and variations thereof (e.g., "comprise" and "comprises"), and illustratively do not exclude additional, unrecited elements or method steps.

[0081] As used in this specification and the appended claims, the singular forms "a", "an", and "the" encompass, include, and specifically disclose both singular and plural referents, unless the context clearly dictates otherwise. For example, reference to a "vector" encompasses and specifically discloses one nucleic acid as well as two or more nucleic acids. Similarly, use of multiple referents does not necessarily require a plurality of such referents, but rather encompasses, includes, and specifically discloses one, as well as two or more such referents, unless the context clearly dictates otherwise.

[0082] For the sake of brevity, the disclosure can quote a list or scope of numerical value.It should also be understood that, in the case of disclosing or enumerating two or more values, or the range of values ​​(for example, less than, greater than, at least, and / or up to a certain value, and / or between two enumerated values), any specific value or value range falling into the disclosed value or value range is also specifically disclosed and covered herein.Therefore, the disclosure of the exemplary measured value (for example, length, width, thickness, etc.) less than or equal to about 10 units or between 0 and 10 units, illustratively includes the following specific disclosure: (i) 9 units, 5 units, 1 unit or any other measured value between 0 and 10 units, including 0 unit and / or 10 units; and / or (ii) between 9 units and 1 unit, between 8 units and 2 units, between 6 units and 4 units and / or between 0 and 10 units. The measured value of any other scope.

[0083] As used herein, "article of manufacture" includes compositions, preparations, mixtures, kits, systems, etc. Similarly, "method" includes processes, procedures, steps, and the like.

[0084] As used herein, with respect to a value, the term "about" or "approximately" generally means or implies + / -10% of the stated value or the amount represented thereby. In addition, throughout this disclosure, the term "about" is used in conjunction with the percentage concentration or composition of a component or ingredient. In this case, the term "about" or "approximately" and / or the term "+ / -10%" implies and / or includes + / -10% of the numerical value, rather than + / -10 percentage points of the percentage. For example, when 20% w / w of a component or ingredient reflects 20g of a component or ingredient per 100mL total mixture, the term "about" and / or the term "+ / -10%" implies and / or includes the range from 18g to 22g (i.e., from 18% w / w to 22% w / w), rather than the range from 10% w / w to 30% w / w. So-called “about” values ​​and / or alternative values ​​of + / -10% include + / -1%, + / -2%, + / -3%, + / -4%, + / -5%, + / -6%, + / -7%, + / -8% or + / -9% of the stated value, each of which is encompassed as a suitable alternative or substitute for the use of the term “about” or + / -10% herein.

[0085] As used herein, the term "substantially" means or implies an amount (or any amount) that is close to a stated amount (e.g., still performs a required function or achieves a (desired, expected, or desired) result). For example, the term "substantially" may refer to an amount within 10%, 5%, 1%, 0.1%, 0.01%, or other percentage of a stated amount or an amount that is less than a stated amount. As used herein, the term "substantially free" refers to (1) an undetectable or unquantifiable amount, (2) less than or below an amount that one skilled in the art would typically consider to reflect a detectable or quantifiable amount, and / or (3) less than or below an amount that one skilled in the art would typically consider to be functional or capable of achieving a (desired, expected, or desired) result (e.g., less than 10%, 5%, 1%, 0.1%, 0.01%, or other percentage).

[0086] Percentage concentrations or compositions provided herein represent values ​​measured as w / w percent, w / v percent, or v / v percent.

[0087] As will be appreciated by those skilled in the art, a "hectare" (abbreviated "ha") is a metric unit of area, primarily used for the measurement of land, and is equal to 100 acres (10,000 m 2 ) or 1 square meter (hm 2 ). One acre is about 0.405 hectares and one hectare contains about 2.47 acres.

[0088] Various aspects or embodiments of the present disclosure may be described by describing components that are combined, coupled, attached, connected, and / or joined together. As used herein, the terms "combined," "coupled," "attached," "connected," and / or "joined" are used to indicate a direct association between two components, or, where appropriate, to be indirectly associated with each other through an insertion or intermediate component. In contrast, when a component is referred to as being "directly combined," "directly coupled," "directly attached," "directly connected," and / or "directly joined" to another component, there is no or no insertion element. In addition, combining, coupling, attaching, connecting, and / or joining may include mechanical, physical, and / or chemical associations.

[0089] In addition, various aspects or embodiments of the present invention may be described by describing components that are mixed together. As used herein, "mixed", "mixed" and similar terms indicate the physical merging or combination of two or more components. In some embodiments, the physical merging or combination results in a (chemical and / or physical) reaction. Such chemical reactions can be demonstrated by changes in the chemical composition, pH or other indicators of the components before mixing (or after mixing without reaction as expected). Therefore, in certain embodiments, the components that will be mixed and / or mixed can be included in the reacted and / or reacted components. Therefore, referring to the components that will be mixed or mixed includes referring to the reacted or reacted components.

[0090] The term "co-administration" and similar terms refer to the simultaneous, sequential and / or combined administration of two or more components. For example, by applying each component in parallel, simultaneously or sequentially (e.g., different applications separated by time periods) in a separate administration, two components can be co-administered. The time period can be very short (e.g., substantially immediately after the first administration) or longer (e.g., 1-60 seconds, 1-60 minutes, 1-24 hours, 1-7 days, 1-4 weeks, 1-12 months, etc., or any value or range of values ​​therebetween). The concurrent or simultaneous administration can include the overlapping administration time range of two or more components or the administration of a combination product including a mixture of two or more components.

[0091] The term "comprising" is synonymous with "including," "having," "containing," or "characterized by." These terms are inclusive and open-ended, and do not exclude other uncited elements or method steps. The phrase "consisting of" excludes any element, step, or ingredient not specified in the claim. When the phrase appears in a clause of the body of a claim, rather than immediately following the preamble, it is limited only to the elements set forth in the clause; other elements are not excluded from the claim as a whole. The phrase "consisting essentially of" limits the scope of the claim to the specified substances or steps, as well as substances or steps that do not materially affect the basic and novel characteristics of the claimed subject matter. The terms "comprising," "consisting of," and "consisting essentially of" may be used interchangeably. When one of these three terms is used, the subject matter currently disclosed and claimed may include the use of any of the other two terms.

[0092] The terms "plurality" and "at least two" are used interchangeably.

[0093] Specific language will be used herein to describe exemplary embodiments. However, it should be understood that this is not intended to limit the scope of the present disclosure. On the contrary, it should be understood that the language used to describe exemplary embodiments is merely illustrative and should not be interpreted as limiting the scope of the present disclosure (unless such language is explicitly described as necessary in this article).

[0094] Although the detailed description is divided into multiple sections, the section headings and contents within each section are for organizational purposes only and are not intended to be independent descriptions and embodiments, or to limit the scope of the description or claims. Instead, the contents of each section in the detailed description are intended to be read and understood as a whole, with elements of one section belonging to and / or informing other sections. Therefore, embodiments specifically disclosed in one section may also be related to and / or used as additional and / or alternative embodiments in another section with the same and / or similar products, methods, and / or terms.

[0095] Embodiments of the present disclosure include plant treatment (e.g., crop protection) products (e.g., compositions, systems, kits, etc.) and methods (e.g., processes, steps, etc.) for making and using the same. Specifically, embodiments of the present disclosure relate to a plant treatment product comprising a plant treatment component mixed with a microbial fermentation product, and methods of making and / or using the plant treatment product (e.g., to enhance the health of crops). In some embodiments, the plant treatment component may be or include a pesticide or a PGR. In some embodiments, the microbial fermentation product may be in liquid (e.g., a suspension) or substantially dry (e.g., in combination with a carrier). In some embodiments, the plant treatment product may include one or more additional ingredients.

[0096] Some embodiments include methods of making plant treatment products. The methods may include mixing plant treatment components with microbial fermentation products. Additional embodiments include methods of enhancing plant health. The methods may include administering or applying an effective amount of a plant treatment product to a plant to improve one or more health indicators of a plant or plant population (e.g., compared to a control group). Each of the foregoing and other embodiments will now be discussed in more detail, including their specific components, features, and / or characteristics.

[0097] Exemplary fermentation products

[0098] As used herein, (microorganisms, bacteria, yeast, fungi, etc.) "fermentation products" or similar terms refer to products of anaerobic metabolism or cellular respiration (e.g., by one or more microorganisms) for at least a period of time as understood by those skilled in the art, rather than just (e.g., these microorganisms on or in a growth medium) bulk growth or other growth. In a certain embodiment, the fermentation product may also come from (one or more periods of) aerobic metabolism. The fermentation product may include concentrated and / or extracted fermentation products, filter cakes, fermentation solubles, fermentation extracts, dried fermentation solubles, liquid fermentation products, dried fermentation biomass, or a combination thereof. As used herein, "liquid fermentation products" or similar terms refer to fermentation products in liquid form. For example, a liquid fermentation product may be or contain a component of a liquid fermentation culture (e.g., a whole or complete microbial fermentation suspension culture), including (at least partially consumed or post-fermented) liquid culture medium or its components, one or more microorganisms and / or their cell material (e.g., structural components), one or more (fermentation, anaerobic, aerobic and / or other) metabolites (produced by microorganisms) and other components known in the art.

[0099] Microbial fermentation products can be processed (e.g., purified, filtered, isolated, separated, etc.) or crude (e.g., unprocessed). In some embodiments, fermentation products can comprise substantially unpurified products of microbial anaerobic (and optionally aerobic) metabolism, including one or more (fermentation) metabolites, (liquid) fermentation medium (e.g., remaining after the fermentation process), and / or microbial cells and / or structural components (e.g., whole cell lysate).

[0100] In at least one embodiment, the fermentation product includes one or more microorganisms and / or cell materials, such as cell structure components, organelles, genetic material, macromolecules or other components thereof. As used herein, the terms "microorganism", "microorganism organism", "microorganism" etc. refer to species or strains of bacteria, archaea, certain protozoa, fungi such as yeast, molds, etc. and algae, as understood by those skilled in the art, whether unicellular or multicellular organisms, whether prokaryotic or eukaryotic. In certain embodiments, the fermentation product includes (whole cell) lysis microorganisms. One or more microorganisms may include any number of microbial species or strains, including but not limited to one, two, three, four, five, six, seven, eight, nine, ten or any other number of discrete (e.g., individually identifiable) microbial species or strains.

[0101] Exemplary bacteria may include, but are not limited to, species or strains of the genus Acetobacter, including Acetobacter, Acetobacter xylinum, Hypoxora, etc.; species or strains of the genus Bacillus, including Alveolar, Azotobacillus, Brevibacterium, Bacillus cereus, Bacillus circulans, Bacillus coagulans, Bacillus laterosporus, Bacillus lentus, Bacillus licheniformis, Bacillus alkaliphilus, Bacillus marineus, Bacillus megaterium, Bacillus pasteurianus, Polymyxa, Paenibacillus dust, Bacillus brevis, Bacillus schreiberi, Bacillus sphaericus, Bacillus stearothermophilus, Bacillus subtilis, Bacillus thiamine soluble, Bacillus thuringiensis, Bacillus thermophilus, etc.; species or strains of the genus Bacteroides, including Bacteroides amylovora, Bacillus lactis, Bacteroides rumeninus, Bacteroides suis, etc.; species or strains of the genus Bifidobacterium, including Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium thermophilus, etc.; species or strains of the genus Enterococcus, including Streptococcus lactis, Streptococcus diacetate, etc. bacteria, Enterococcus faecium, Intermediate coccus, Lactobacillus, Streptococcus thermophilus, etc.; species or strains of Lactobacillus, including Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus buchneri, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus cellobiose, Lactobacillus curvus, Lactobacillus delbrueckii, Lactobacillus sausage, Lactobacillus fermentation, Lactobacillus helveticus, Lactobacillus lactis, Lactobacillus plantarum, Lactobacillus reuteri, etc.; species or strains of Leuconostoc, including Leuconostoc aurantiacus, Leuconostoc glucanus, Leuconostoc mesenteroides, etc.; species or strains of Megacoccus Strains, including Megasphaera elsdenii, etc.; species or strains of Pediococcus, including Pediococcus acidilactici, Saccharomyces cerevisiae (damanosus), Pediococcus pentosaceus, etc.; species or strains of Propionibacterium, including Propionibacterium freudenreichii, Propionibacterium stutzeri, etc.; species or strains of Rhodopseudomonas, including Rhodopseudomonas palustris, etc.; and / or species or strains of Streptococcus, including Leuconostoc creamer, Streptococcus aceticolic acid, Streptococcus faecalis, Streptococcus intermedius, Streptococcus lactis, Streptococcus salivarius, Streptococcus thermophilus, etc. Other embodiments include, for example, species or strains of Streptomyces, including Streptomyces avium, Chatanogonia, Chattanooga Streptomyces, Streptomyces griseus, etc.; species or strains of Xanthomonas, including Streptomyces campestris, etc.; species or strains of Rhizopus, including Rhizopus niveus, etc.; species or strains of Micrococcus, including Micrococcus lysodeikticus, etc.; species or strains of Bacillus, including Bacillus cereus, etc.; and / or species or strains of Leuconostoc, including Leuconostoc aurantiacum, Leuconostoc glucosidase, etc.

[0102] In at least one embodiment, the fermented product can include a first species and / or strain of lactobacillus (e.g., Lactobacillus acidophilus) and / or its cell or structural components (e.g., cracked lactobacillus species). In some embodiments, the fermented product can include one or more additional microorganisms (e.g., bacteria, fungi, yeasts, molds, algae) species or strains (such as one or more of those listed herein) and / or its cell or structural components. For example, the fermented product can include one or more additional cracked bacterial species or strains, rather than the first species or strain of Lactobacillus.

[0103] In some embodiments, the one or more microorganisms or additional microorganisms do not include bacteria or bacterial species or strains. In some embodiments, the plant treatment product or its microbial fermentation product may be substantially free of bacteria and / or its cells or structural components. For example, in some embodiments, the fermentation product may be a fungal (e.g., yeast and / or mold) fermentation product substantially free of bacteria and / or its cells or structural components. Exemplary fungi may include, but are not limited to, yeasts of the Ascomycota, such as the Saccharomyces subphylum and / or the Exocystomycota subphylum (e.g., Schizosaccharomyces class), and / or Basidiomycetes, such as the Agaricomycetes subphylum (e.g., Tremella class) and / or the Puccinia subphylum (e.g., Microspherical Ustilago class). Exemplary yeasts may include species or strains of the genus Candida (formerly known as the genus Torulopsis), including Candida utilis, Candida glabrata, Candida moniliformis, Candida lipolytica, Candida pseudotropicalis, etc.; species or strains of the genus Kluyveromyces, including Kluyveromyces lactis, etc.; and / or species or strains of the genus Saccharomyces, including Saccharomyces cerevisiae, Saccharomyces boulardii, Saccharomyces fragilis, etc. Exemplary fungi may further include species or strains of Aspergillus, including Aspergillus niger, Aspergillus oryzae, etc.; species or strains of Penicillium, including Penicillium roqueforti, etc.; species or strains of Mucor, including Mucor miehei, Mucor microsporus, etc.; species or strains of Mortierella, including Porphyromycin, etc.; species or strains of Endocytosis, including Parasitemia, etc.; and / or species or strains of Rhizomucor, including Rhizomucor miehei, etc.

[0104] In certain embodiments, plant treatment products or their microbial fermentation products can be substantially free of fungi, yeast, mold and / or any one or more of the aforementioned cells or structural components. For example, in certain embodiments, the fermentation product can be a bacterial fermentation product that is substantially free of fungi, yeast, mold and / or any one or more of the aforementioned cells or structural components. Some embodiments can be substantially free of mold and / or its cells or structural components. In certain embodiments, the fermentation product can be a bacterial and / or yeast fermentation product that is substantially free of mold and / or its cells or structural components. Some embodiments can be substantially free of algae and / or its cells or structural components. Certain embodiments can include at least one bacterial species or strain, at least one fungi (or yeast, or mold) species or strain, and / or at least one algae species or strain.

[0105] In at least one embodiment, one or more microorganisms of fermented product can be spore form, growth form, metabolic form or its combination. However, in some embodiments, one or more microorganisms of fermented product can be non-living, inactive, non-metabolism and / or cracking. Therefore, fermented product can include one or more non-living, inactive, non-metabolism and / or cracking microorganisms or their cell materials (such as cell structure components). In addition, fermented product can be substantially free of one or more or any living (such as, metabolic, dormant, spore-forming, etc.) microorganisms. For example, fermented product can include less than about 50%, less than about 40%, less than about 30%, less than about 25%, less than about 20%, less than about 15%, less than about 10%, less than about 5%, less than about 1%, less than about 0.5%, less than about 0.25%, less than about 0.1%, less than about 0.05%, less than about 0.01% or less living or vigorous microorganisms. Thus, while probiotic products or products containing feed microorganisms (DFM) may contain live cultures, live or viable naturally occurring microbial sources, etc., some embodiments of the present disclosure may include microbial fermentation products that are substantially or completely free of live or viable microorganisms. Specifically, as known in the art, the microorganisms may be intentionally killed and / or inactivated (e.g., by lysis, such as by sonication, vigorous mixing or blending, heat inactivation, pH inactivation, etc.).

[0106] As mentioned above, the fermentation product may also include a liquid (fermentation) culture medium (e.g., remaining after the fermentation process). Thus, the fermentation product may include a product of a liquid suspension (fermentation) culture of a microorganism grown under anaerobic (and optionally aerobic) conditions. The culture medium may include a liquid base component, such as water or a nutrient broth (e.g., lysogeny broth (LB), M9, liquid thioglycolate medium (FTM), NZ, NZY or NZYM broth, SOB, super broth, 2X, YT, MOPS, SOC, TB, etc.). The culture medium may also include one or more nutrients, growths and / or other components (e.g., remaining after the fermentation process), such as a carbon source (e.g., carbohydrates, such as glucose, sucrose, fructose, lactose, galactose, etc.), an (inorganic) nitrogen source, a protein or amino acid source (e.g., a synthetic protein or amino acid, a natural, plant and / or animal-derived protein or amino acid, etc.), a vitamin (e.g., thiamine, riboflavin, folic acid, pantothenic acid, niacin, vitamin B 12 , vitamin E, pyridoxine, vitamin D, vitamin K, vitamin A, choline, etc.), minerals, trace elements (e.g., copper, iron, manganese, zinc, molybdenum, chromium, selenium, etc.), essential elements (e.g., magnesium, nitrogen, phosphorus, sulfur), salts (e.g., potassium phosphate, sodium phosphate, sodium chloride, ammonium chloride, magnesium sulfate, calcium chloride, etc.), yeast extracts, enzymes and / or any other suitable (fermentation) culture components known to those skilled in the art. In addition, certain fermentation products may explicitly exclude one or more of the aforementioned or other known culture components (e.g., serum, growth factors, hormones, enzymes, antibiotics, beef extract, whole blood, heat-treated blood, etc.).

[0107] Fermented products can include one or more metabolites. In at least one embodiment, one or more metabolites include fermentation or other metabolites produced by microorganisms (e.g., during anaerobic and optional aerobic metabolism). Microbial fermentation metabolites can include but are not limited to one or more organic acids (e.g., lactic acid, acetic acid, formic acid, etc.), amino acids, carbohydrates, fats, fatty acids, enzymes, vitamins and / or any other microbial metabolite components known to those skilled in the art. Metabolites can be nutritionally beneficial to one or more plants or crops, or to the microorganisms associated therewith. In certain embodiments, metabolites can include one or more microbial waste products. In at least one embodiment, fermented products can be substantially free of antimicrobial agents (e.g., bacteriocins, antibiotics, hydrogen peroxide, etc.); certain enzymes (e.g., proteases, amylases, lipases, glycosidases, DNA and / or RNA polymerases), etc.

[0108] In some embodiments, the metabolites may be at least partially purified (e.g., removing unwanted substances such as waste products, fermentation medium, microbial cells and / or structural substances, etc.). Alternatively, in one or more embodiments, the metabolites may be substantially unpurified. Substantially unpurified metabolites may be placed in a microorganism and / or (liquid) fermentation medium (e.g., outside the microorganism). In some embodiments, the microorganism may be lysed (e.g., so that substantially all metabolites are free in solution (i.e., not contained in the microorganism)). Thus, in some embodiments, the fermentation product may comprise a mixture (e.g., solution, colloid, suspension, colloidal suspension, emulsion, etc.) of post-fermentation liquid medium, one or more microbial fermentation metabolites (e.g., anaerobic and / or aerobic metabolites), and microbial cells and / or structural components (e.g., whole cell lysate). In at least one embodiment, the mixture may be crude, unprocessed, and / or substantially unpurified.

[0109] Exemplary fermentation methods, parameters, etc. include those known to those skilled in the art. Fermentation products can be prepared by one or more fermentation processes, including culturing one or more microorganisms (e.g., bacteria) species or strains or cell lines on solid growth medium, as known in the art. In some embodiments, microbial cultures can grow under natural and / or environmental conditions. In other embodiments, cultures can grow under artificial and / or optimized conditions. Microbial cultures can grow under biologically suitable temperatures (e.g., about 20-50 degrees Celsius (° C.) or about 30-40° C.), acidity (pH) (e.g., about 3.0-8.0), etc. In addition, the growth medium may include one or more of the above-mentioned or other culture medium components, including but not limited to (substantially solid) base components (e.g., agar or other suitable base components), nutrients, and / or other components (e.g., carbon and / or (inorganic) nitrogen sources, vitamins, minerals, trace elements, essential elements, amino acids, amino acid sources, salts, yeast extracts), and / or any other culture components known to those skilled in the art. In at least one embodiment, microbial cultures can grow under aerobic and / or anaerobic conditions.

[0110] In some embodiments, as known in the art, the fermentation method can also include inoculating one or more (live) microorganisms or microbial systems (or colonies thereof) into a liquid growth medium (e.g., to form a starting suspension culture). As described above, the liquid (suspension) culture can also be grown under natural and / or environmental or artificial and / or optimized conditions. The liquid growth medium can include one or more of the above or other medium components.

[0111] In at least one embodiment, vigorous starting culture (or its suitable part, comprises its full fraction, extract, cell precipitation etc.) can be transferred in liquid fermentation medium (for example, to form liquid fermentation culture).Liquid fermentation medium and / or culture can be placed in bioreactor, flask or other suitable growth container.In addition, liquid fermentation medium and / or culture can comprise one or more above-mentioned or other culture medium components.Similarly, as mentioned above, liquid fermentation culture also can grow under natural and / or environmental or artificial and / or optimized condition.In at least one alternative embodiment, one or more vigorous microorganisms or microorganism system (or its bacterium colony) can be directly inoculated in liquid fermentation medium.

[0112] As known in the art and described herein, the fermentation culture can be grown for a first period of time and / or under first fermentation conditions under anaerobic and / or aerobic conditions. For example, the fermentation culture can be grown for about 0.5 days to about 5 days at a temperature of about 10-50°C and / or at a pH of about 2-10. As known in the art and described herein, after the first period of time, the fermentation culture can be grown for a second period of time and / or under second fermentation conditions under anaerobic and / or aerobic conditions. For example, the second period of time can be between 0.5 days and about 5 days. The second fermentation conditions may include a temperature of about 10-50°C, a pH of about 2 to about 10, etc. In some embodiments, the second period of time and / or the second fermentation conditions may be different from the first period of time and / or the first fermentation conditions. For example, the fermentation culture (or a suitable portion thereof) can be transferred to a second fermentation condition and / or a second fermentation medium. The second fermentation medium may be placed in a bioreactor, a flask or other suitable growth container and / or may include one or more of the above or other culture medium components.

[0113] It should be understood that, as known in the art and described herein, fermentation process can also include additional time period, fermentation conditions, fermentation medium, etc. When fermentation process is completed, fermentation culture can be or include microbial fermentation product and / or can be optionally and / or processed in addition to form microbial fermentation product. For example, in certain embodiments, the microorganism (anaerobic and / or aerobic metabolism) of fermentation culture can be killed and / or inactivated intentionally (for example, by cracking, such as by ultrasonic treatment, violent mixing or blending, heat inactivation, pH extinguishing or killing, etc.). In at least some embodiments, the fermentation metabolites in the microbial cells or organisms placed in the fermentation culture can be released into the culture medium (for example, so that metabolites are free in solution or other liquid culture medium types). Non-living, inactive, non-metabolized and / or cracked microorganisms or their cell materials (cellular structure components) can be retained in the liquid fermentation medium, or at least partially (for example, substantially and / or completely) removed therefrom (for example, by (ultra) centrifugation, filtration, etc.). In certain embodiments, the fermentation product comprises a whole cell and / or whole culture lysate of a fermentation culture (e.g., without substantial removal, purification, isolation, etc. of one or more (e.g., any) components of the fermentation culture). However, in alternative embodiments, one or more components of the fermentation culture may be at least partially and / or substantially removed, purified, isolated, etc. Thus, the fermentation product may be in a substantially liquid (suspension, solution, colloid, gel, slurry, etc.) form and / or may include one or more components of a microbial fermentation culture (e.g., prepared as described herein and / or known in the art). In at least one exemplary embodiment, the fermentation product may comprise a liquid suspension comprising substantially unpurified products of anaerobic and optionally aerobic metabolism of the microorganism, including (i) substantially all (fermentation) metabolites produced by the fermentation culture, (ii) liquid fermentation medium in which the fermentation culture was cultured (e.g., remaining after the fermentation process), and (iii) a whole cell lysate of a microorganism or culture, including all microbial cells and / or structural components of the microorganism grown in the fermentation culture. Alternatively, the fermentation product can be in a substantially solid form (eg, dried, freeze-dried, vacuum-dried, heat-dried, dehydrated, extracted, etc.) comprising one or more of the foregoing components of the fermentation culture.

[0114] Exemplary vectors

[0115] As used herein, "carrier," "excipient," and similar terms refer to a component suitable for transporting a substance. For example, a carrier component may include a solid, dry, and / or substantially dry carrier. In at least one embodiment, the carrier may include an organic and / or earthy carrier comprising one or more organic and / or earthy components or substances. The earthy carrier, component, and / or substance may include, for example, phyllosilicates (e.g., phyllosilicates of potassium (K), sodium (Na), calcium (Ca), and / or aluminum (Al)). The phyllosilicate may be chlorite, clay, mica, or serpentine. In at least one embodiment, the carrier may include one or more 1:1 or 2:1 clay mineral phyllosilicates.

[0116] Exemplary carriers may include, but are not limited to, forsterite, attapulgite, beidellite, bentonite, biotite, calcium silicate, calcium stearate, chlorite (e.g., clinochlorite, oolite, nickel chlorite, spessartite, and / or its zinc, lithium, and / or calcium species), hectorite, diatomaceous earth and / or other diatomaceous earth products, dickite, glauconite, halloysite, hectorite, hydrophobic silica, illite, kaolin, kaolinite, montmorillonite, muscovite, nacrite, nontronite, palygorskite, phyllite, soapstone, sauconite, sepiolite, sericite, serpentine, smectite, talc, clay and vermiculite. Some carriers may be or include naturally occurring substances or components. Other carriers may be or include artificial and / or synthetic substances or components. The carrier may also include (dried) plant matter and / or extracts, meal, flour, protein powder, seaweed, etc.

[0117] In some embodiments, the carrier can have a water content of less than about 20% by weight, a water content of less than about 15% by weight, a water content of less than about 10% by weight, a water content of less than about 5% by weight, a water content of less than about 3% by weight, a water content of less than about 2% by weight, or a water content of less than about 1% by weight. In at least one embodiment, the carrier can have the following water content by weight: a water content between about 0.25% and about 1%, 2%, 3%, 4%, 5%, 10%, 15% or 20%, a water content between about 0.5% and about 1%, 2%, 3%, 4%, 5%, 10%, 15% or 20%, a water content between about 1% and about 2%, 3%, 4%, 5%, 10%, 15% or 20%, or a water content between about 2% and about 3%, 4%, 5%, 10%, 15% or 20%. As used herein, the term "substantially dry carrier" refers to a carrier having one or more of the aforementioned moisture contents. Such a substantially dry carrier can generally be understood as a solid, dry material, but still having at least some moisture associated with it.

[0118] In some embodiments, the carrier can be in the form of a powder, granules and / or particles or have an average particle size of about 20-297 microns (e.g., corresponding to about 625-50 meshes). In at least one preferred embodiment, the carrier can have an average particle size of about 74 microns (or about 200 meshes) + / - 20%, + / - 15%, + / - 10%, + / - 8% or + / - 5%. In certain embodiments, the solid carrier size can be set (e.g., by grinding, crushing, grinding, etc.) to a suitable average particle size. Therefore, in some embodiments, the solid carrier can be a mined and ground soil component with a suitable average particle size.

[0119] In at least one embodiment, the fermented product can be combined with a carrier to form a carrier combined with the fermented product. For example, the fermented product can be physically and / or chemically bound to the carrier (for example, by chemical reaction or means). In some embodiments, the fermented product can be combined with the carrier by static electricity or by a force other than (general or macroscopic) static electricity. In certain embodiments, the combination of the fermented product with the carrier can increase the bioavailability of at least one metabolite (for example, relative to being free in solution or extracting, purifying and / or isolating from a solution or cell). Therefore, the fermented product can be applied to the carrier, bound to the outer surface of the carrier, and / or bound to a part of the carrier adjacent to or below the surface. For example, in some embodiments, at least a portion of the liquid fermented product can be (i) adsorbed to the surface of the carrier and / or (ii) adsorbed below the surface of the carrier. The liquid fermented product can also be combined to the carrier by drying on the carrier and / or drying therein after being applied to the carrier. Therefore, in certain embodiments, the liquid fermented product can be at least partially combined with the carrier dry. As used herein, "dry bond" and like terms refer to a durable and / or sustained physical association of two or more substances through physical and / or chemical forces established during the drying process.

[0120] In at least one embodiment, the fermented product can substantially or at least partially cover the carrier. For example, the fermented product can be applied to the carrier (for example, so that the liquid portion of the fermented product does not dissolve the carrier and / or so that the applied portion of the fermented product substantially or at least partially covers the surrounding carrier). In certain embodiments, at least a portion of the fermented product can be chemically combined with the carrier. For example, the fermented product can react with the carrier (for example, so that a physical and / or chemical binding reaction occurs). The reaction can be endothermic or exothermic. In addition, the reaction can be promoted and / or accelerated by one or more enzymes or other reaction components or parameters (for example, heat, air (flow), mixing, etc.). The enzyme or other components can be metabolic reaction products, fermentation culture components and / or separate components added before or during the fermented product is applied to the carrier.

[0121] In some embodiments, the carrier combined with the fermented product can be in solid form. For example, the carrier combined with the fermented product can have a water content of less than about 20% by weight, a water content of less than about 15% by weight, a water content of less than about 10% by weight, a water content of less than about 5% by weight, a water content of less than about 3% by weight, a water content of less than about 2% by weight, or a water content of less than about 1% by weight. In at least one embodiment, the carrier combined with the fermented product can have the following water content by weight: a water content between about 0.25% and about 1%, 2%, 3%, 4%, 5%, 10%, 15% or 20%, a water content between about 0.5% and about 1%, 2%, 3%, 4%, 5%, 10%, 15% or 20%, a water content between about 1% and about 2%, 3%, 4%, 5%, 10%, 15% or 20%, or a water content between about 2% and 3%, 4%, 5%, 10%, 15% or 20%. Therefore, the carrier combined with the fermented product can be substantially dry. In other embodiments, the carrier combined with the fermented product can be in the form of a substantially liquid (suspension, solution, colloid, gel, slurry, etc.).

[0122] In one or more embodiments, the fermented product can be combined with a carrier so that the fermented product and / or one or more components thereof are maintained at a suitable pH or pH range, or in an environment with a suitable pH or pH range. For example, in some embodiments, the carrier and / or the carrier combined with the fermented product can provide and / or have a pH between about 2 and 10, preferably between about 2 and 8, more preferably between about 2 and 6, still more preferably between about 2 and 5, still more preferably between about 2 and 4, still more preferably between about 2 and 3, still more preferably between about 3 and 10, still more preferably between about 3 and 8, still more preferably between about 3 and 6, still more preferably between about 3 and 5, still more preferably between about 3 and 4, still more preferably between about 4 and 10, still more preferably between about 4 and 8, still more preferably between about 4 and 6, still more preferably between about 4 and 5.

[0123] The carrier component may also or alternatively comprise a liquid or liquid composition (e.g., a solution, a suspension, a colloid, a mixture, etc.). Exemplary liquid carriers include, but are not limited to, water or other aqueous liquids, oils, or any suitable liquid composition or carrier, such as a solvent (of a solution), a continuous phase (of a colloid), an external phase (of a suspension), etc. In some embodiments, the (liquid) carrier may be or comprise a culture medium, such as a suspension medium. In at least one embodiment, the fermentation product may be mixed with a carrier to form a diluted or mixable fermentation product.

[0124] Exemplary Plant Treatment Components

[0125] Exemplary plant treatment components include one or more of the following: (1) pesticides, preferably selected from the group consisting of: (i) insecticides (e.g., to control Lepidoptera, Hemiptera, Diptera, Coleoptera, etc.), (ii) non-insecticide pesticides (e.g., to control rodents, amphibians, etc.), (iii) antimicrobial pesticides (e.g., fungicides, bactericides, antibiotics, antiparasitic agents, antivirals, etc.), (iv) herbicides (selective or non-selective) and (v) nematicides; and (2) PGRs. In certain embodiments, the plant treatment components may include fertilizers. In preferred embodiments, the plant treatment product or its plant treatment components may be (substantially or completely) free of one or more fertilizers (e.g., urea and / or nitrogen-containing fertilizers). The plant treatment components and / or its plant treatment components may be (substantially) dry, solid or liquid.

[0126] Exemplary Insecticides

[0127] In some embodiments, the pesticide can be or include a (chemical) insecticide. A variety of (chemical) insecticides are commercially available and known to those skilled in the art, each of which is encompassed herein. Exemplary (chemical) insecticides include sodium channel modulators and voltage-dependent sodium channel blockers. In at least one embodiment, the sodium channel modulator and / or voltage-dependent sodium channel blocker is selected from the group consisting of: pyrethroids, DDT (I139), methoxychlor (I140), indoxacarb (I219), cyanamide (I220) and combinations thereof. In one embodiment, the sodium channel modulator and / or voltage-dependent sodium channel blocker is selected from the group consisting of flumethrin (I96), allethrin (I97), d-cis-trans allethrin (I98), d-trans allethrin (I99), bifenthrin (I100), bio-allethrin (I101), bio-allethrin S-cyclopentenyl isomer (I102), d-trans-pyrethrin (I103), cypermethrin (I104), flucythrin (I105), d-cyclopentenyl isomer (I106), d-cyclopentenyl isomer (I107), d-cyclopentenyl isomer (I108), d-cyclopentenyl isomer (I109), d-cyclopentenyl isomer (I111), d-cyclopentenyl isomer (I112), d-cyclopentenyl isomer (I113), d-cyclopentenyl isomer (I114), d-cyclopentenyl isomer (I115), d-cyclopentenyl isomer (I116), d-cyclopentenyl isomer (I117), d-cyclopentenyl isomer (I118), d-cyclopentenyl isomer (I119), d-cyclopentenyl isomer (I120), d-cyclopentenyl isomer (I121), d-cyclopentenyl isomer (I122), d-cyclopentenyl isomer (I123), d-cyclopentenyl isomer (I124), d-cyclopentenyl isomer (I125), d-cyclopentenyl isomer (I126), d-cyclopentenyl isomer (I127), d-cyclopentenyl isomer (I128), d-cyclopentenyl isomer (I129), d-cyclopentenyl isomer (I130), d-cyclopenten 105), β-cyfluthrin (I106), cyhalothrin (I107), λ-cyhalothrin (I108), γ-cyhalothrin (I109), cypermethrin (I110), α-cypermethrin (I111), β-cypermethrin (I112), θ-cypermethrin (I113), ζ-cypermethrin (I114), phenothrin [(1R)-trans isomer] (I115), deltamethrin (I116), cypermethrin [(EZ)-(1R)-trans isomer] (I117), cis-cypermethrin (I118), ethomethrin (I119), cypermethrin (I120), cypermethrin (I121), flucythrinate (I122), flumethrin (I123), fluvalinate (I124), benzylfenthrin (I125), imiprothrin (I126), thienthrin (I127), permethrin (I128), phenothrin [(1R)-trans isomer (I 129), cypermethrin (I130), pyrethrin (I131), resmethrin (I132), silafluthrin (I133), tefluthrin (I134), tetramethrin (I135), tetramethrin [(1R) isomer)] (I136), tralomethrin (I137), transfluthrin (I138), DDT (I139), methoxychlor (I140), indoxacarb (I219), metaflumizone (I220) and their combinations.

[0128] According to at least one embodiment of the present disclosure, the at least one insecticide is selected from the group consisting of: acralthrin (I96), α-cypermethrin (I111), β-cypermethrin (I106), bifenthrin (I100), cypermethrin (I105), cypermethrin (I110), deltamethrin (I116), γ-cyhalothrin (I109), λ-cyhalothrin (I108), tefluthrin (I134), indoxacarb (I219), and metaflumizone (I220). In some embodiments, the at least one insecticide is selected from the group consisting of: β-cyhalothrin (I106), deltamethrin (I116), tefluthrin (I134), and combinations thereof. In some embodiments, the at least one insecticide is selected from the group consisting of: (1) acetylcholinesterase (AChE) inhibitors, such as carbamates, such as benfuracarb (I1), aldicarb (I2), benfuracarb (I3), benfuracarb (I4), butanone carb (I5), butanone sulfacarb (I6), carbaryl (I7), carbofuran (I8), butanone carb (I9), thiocarb (I10), fenbutyl carb (I11), fenthiocarb (I12), furathiocarb (I13), isoprocarb (I14), methiocarb (I15), methomyl (I16), or organophosphates, such as acephate (I27), methylpyrifos (I28), azoxystrobin (I29), azoxystrobin (I30), cadastrefos (I31), chlorpyrifos (I32), chlorfenapyr (I33), chlormethin (I34), chlorpyrifos (I35), chlorpyrifos (I36), chlorpyrifos (I37), chlorpyrifos (I38), chlorpyrifos (I39), chlorpyrifos (I40), chlorpyrifos (I41), chlorpyrifos (I42), chlorfenapyr (I43), chlorfenapyr (I44), chlorpyrifos (I45), chlorpyrifos (I46), chlorpyrifos (I47), chlorpyrifos (I48), chlorpyrifos (I49), chlorpyrifos (I41), chlorpyrifos (I41), chlorpyrifos (I42), chlorpyrifos (I43), chlorpyrifos ... 5), methyl chlorpyrifos (I36), coumaphos (I37), cypermethrin (I38), methyl demeton (I39), diazinon (I40), dichlorvos / DDVP (I41), dicrotophos (I42), dimethoate (I43), methyl chlorpyrifos (I44), thiophanate-methyl (I45), fenthion (I46), ethion (I47), ethoxychlor (I48), fenamiphos (I49), fenamiphos (I50), fenthion (I51), fenthion (I52), thiamethoxam (53), heptylphos (I54), nematicides ( I55), isofenphos (I56), O-(methoxyaminothiophosphoryl) salicylic acid isopropyl ester (I57), oxathion (I58), malathion (I59), cypermethrin (I60), methamidophos (I61), methidathion (I62), mefenphos (I63), monocrotophos (I64), dibromophos (I65), omethoate (I66), sulfoxide (I67), parathion (I68), methyl parathion (I69), fenthion (I70), phorate (I71), phosalone (I72), phosmet (I73),Phosphamidon (I74), phoxim (I75), methyl pirimiphos (I76), profenofos (I77), chlorfenvinphos (I78), profenofos (I79), pyraclofos (I80), pyridazinphos (I81), quinalphos (I82), chlorfenvinphos (I83), butyl pirimiphos (I84), temephos (I85), terbufos (I86), chlorpyrifos (I87), methyl sulfamethoxam (I88), triazophos (I89), trichlorfon (I90) and aphidoxam (I91); (2) GABA-gated chloride channel antagonists, for example, cyclopentadienyl organochlorines such as chlordane (I92) and endosulfan (I93); or phenylpyrazoles (fiproles), for example, ethiprole (I94) and fipronil (I95); (3) sodium channel modulators / voltage-dependent sodium channel blockers, for example, pyrethroids, such as flumethrin (I96), allethrin (I97), d-cis-trans-allethrin (I98), d-trans-allethrin (I99), bifenthrin (I100), bio-allethrin (I101), bio-allethrin S-cyclopentenyl isomer (I102), bio-resmethrin (I103), cypermethrin (I104), flucythrin (I105), β-cypermethrin (I106), cyhalothrin (I107), lambda-cyhalothrin (I108), gamma-cyhalothrin (I109), cypermethrin (I1101), β-cyhalothrin (I1102), cypermethrin (I1103), cypermethrin (I1104), cypermethrin (I1105), β-cyhalothrin (I1106), cyhalothrin (I1107), lambda-cyhalothrin (I1108), gamma-cyhalothrin (I1109), cypermethrin (I1110), cypermethrin (I1111), cypermethrin (I1112), cypermethrin (I1113), cypermethrin (I1114), cypermethrin (I1115), β-cyhalothrin (I1116), cyhalothrin (I1117), λ-cyhalothrin (I1118), γ-cyhalothrin (I1129), cypermethrin (I1200), cypermethrin (I1201), cypermethrin (I1202), cypermethrin (I120 I110), α-cypermethrin (I111), β-cypermethrin (I112), θ-cypermethrin (I113), ζ-cypermethrin (I114), phenothrin [(1R)-trans isomer] (I115), deltamethrin (I116), fenvalerate [(EZ)-(1R)-trans isomer] (I117), cis-fenvalerate (I118), ethomethrin (I119), cypermethrin (I120), cypermethrin (I121), flucythrinate (I122), flumethrin (I123), fluvalinate (I124), benzylfen (I125), imiprothrin (I126), thienylthrin (I127), permethrin (I128), 8), phenothrin [(1R)-trans isomer (I129), phenthrin (I130), pyrethrin (pyrethrum) (I131), resmethrin (I132), silafluthrin (I133), tefluthrin (I134), tetramethrin (I135), tetramethrin [(1R) isomer)] (I136), tralomethrin (I137) and transfluthrin (I138); or DDT (I139); or methoxychlor (I140); (4) nicotinic acetylcholine receptor (nAChR) agonists, for example, neonicotinoids, such as acetamiprid (I141), clothianidin (I142), dinotefuran (I143), imidacloprid (I144), nitenpyram (I145),Thiacloprid (I146) and thiamethoxam (I147); or nicotine (I148); or sulfonecarb (I149). (5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, for example, spinosad, such as spinosad (I150) and spinosad (I151); (6) Chloride channel activators, for example, avermectins / milbemycins, such as avermectin (I152), avermectin benzoate (I153), lepidomycin (I154) and mibemycin (I155); (7) Juvenile hormone mimetics, for example, juvenile hormone analogs, such as methoprene (I156), methoprene (I157) and methoprene (I158); or fenoxycarb (I159); or pyriproxyfen (I160); (8) Multi-class nonspecific (multi-site) inhibitors, for example Such as alkyl halides, such as methyl bromide (I161) and other alkyl halides; or chloropicrin (I162); or sulfuryl fluoride (I163); or borax (I164); or tartar emetic (I165); (9) selective homopteran antifeedants, such as pymetrozine (I166); or flonicamid (I167); (10) mite growth inhibitors, such as clofentezine (I168), hexythiazox (I169) and fluazifop (I170); or etoxazole (I171); (11) microbial disruptors of the insect midgut membrane, such as Bacillus thuringiensis subsp. israelii (I172), Bacillus thuringiensis subsp. aizawa (I173), Bacillus thuringiensis subsp. kurstak (I174), 4), Bacillus thuringiensis subsp. tenaro (I175) and Bt crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / 35Ab1 (I176); or Bacillus sphaericus (I177); (12) mitochondrial ATP synthase inhibitors, such as diafenthiuron (I178); or organotin acaricides, such as triazotin (I179), cyclohexyltin (I180) and fenbutatin (I181); or propargite (I182); or tetrachlorfenapyr (I183); (13) by disrupting the proton ladder (I184), dinitrocresol (DNOC) (I185) and flubendiamide (I186); (I4) nicotinic acetylcholine receptor (nAChR) channel blockers, such as chlorfenapyr (I187), cartap hydrochloride (I188), cyfluthrin (I189) and diflubenzuron (I190); (15) chitin biosynthesis inhibitors, type 0, such as bistrifluanyl (I191), flufenoxuron (I192), diflubenzuron (I193), flufenoxuron (I194), flufenoxuron (I195), hexaflumuron (I196), lufenuron (I197), flubendiamide (I198), perflumuron (I199),(16) chitin biosynthesis inhibitors, type 1, such as buprofezin (I202); (17) molting disruptors, such as cyromazine (I203); (18) ecdysone receptor agonists, such as chlorfenapyr (I204), chlorfenapyr (I205), methoxyfenapyr (I206) and tebufenozide (I207); (19) octopamine receptor agonists, such as amitraz (I208); (20) mitochondrial complex III electron transport inhibitors, such as hydrazone (I209); or acequinoxaline (I210); or cypermethrin (I211); (21) mitochondrial complex I electron transport inhibitors, such as chlorfenapyr (I201); or chlorfenapyr (I202); (22) (22) voltage-dependent sodium channel blockers, for example indoxacarb (I219); or metaflumizone (I220); (23) acetyl-CoA carboxylase inhibitors, for example tetronic acid and tetramic acid derivatives, for example spirodiclofen (I221), spiromesifen (I222) and spirotetramat (I223); (24) mitochondrial complex IV electron transport inhibitors, for example phosphines, such as phosphine Aluminum (I224), calcium phosphide (I225), phosphine (I226) and zinc phosphide (I227); or cyanide (I228); (25) mitochondrial complex II electron transport inhibitors, such as β-ketonitrile derivatives, such as cypermethrin (I229) and cyfluthrin (I230); and (28) lonadan receptor modulators, such as diamides, such as chlorantraniliprole (I231), cyantraniliprole (I232) and flubendiamide (I233), and / or selected from the group consisting of sulfamethoxam (I234), azadirachtin (I235), clofenthiazole (I236), benzathine (I237), bifenazate (I238) , bromocriptine (I239), miticide (I240), cryolite (I241), dicofol (I242), flufenoxazine (I243), fluthiazolin (I244), pyrimidine (I245), butene fipronil (I246), fluopyram (I247), furanfenozide (I248), chlorothiazolin (I249), iprodione (I250), chlorfluazuron (I251), pyridalyl (I252), flufenoxazine (I253), tetrafluthrin (I254) and iodomethane (I255); and based on Bacillus firmus (including but not limited to strain CNCM I-I582, such as VOTiVOTM,BioNemTM) (I256) or one of the following known active compounds: 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide (I257), 4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (I258), 4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one (I259), 4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (I260), 4-{[(6-chloropyridin-3-yl)methyl] ](2-fluoroethyl)amino}furan-2(5H)-one (I261), fluoropyrone (I262), 4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I263), 4-{[,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (I264), 4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one (I265), 4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one (I266), 4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I267),{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxy-λ4-sulfuralkylene}cyanamide (I268) and its diastereoisomers {[(1R)-1-(6-chloropyridin-3-yl)ethyl(methyl)oxy-λ4-sulfuralkylene}cyanamide (A) (I269) and {[(1S)-1-(6-chloropyridin-3-yl)ethyllithiummethyl)oxy-λ4-sulfuralkylene}cyanamide (B) (I270), as well as diastereoisomers [(R)-methyl(oxy){(1R)-1-[6-(6-trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfuralkylene]cyanamide (A1)) (I271) and [(S)-methyl(oxy){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfuralkylene]cyanamide (A2) (I272) [(R)-methyl(oxo){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanyl]cyanamide (A2) (I272), which are referred to as diastereomer A; [(R)-methyl(oxo){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanyl]cyanamide (B1) (I273) and [(S)-methyl(oxo){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanyl]cyanamide (B2) (I274), which are referred to as diastereomer B; and 1,1-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azabispiro[4.2.4.2]tetradec-11-ene-10 -one (I275), 3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-decen-2-one (I276), 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (I277), bicyclopyralid [(3S,4aR,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b -Decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromanyl-4-yl]cyclopropanecarboxylic acid methyl ester (I278), 2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide (I279), 2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide (I280), 2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (I281), 4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine 1,1-dioxide (I282), N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine (I283),{1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4'-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (I284), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]-3-decen-2-one (I285), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxa-1,8-diazaspiro[4.5]-3-decen-4-ylethyl carbonate Ester (I286), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (I287), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile (I288), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile (I289), 8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6(trifluoromethyl) 1-(4-(2-(4-(2-(4-(2-(2-(4-(2-chloro-1-pyridin-4-yl)-1-yl)-2-nitro-1-ol)benzonitrile) (I293), 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (I294), 5-[5-(2-chloropyridin-4-yl)-1-nitro-1-ol]benzonitrile (I295), 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (I296), 5-[5-(2-chloropyridin-4-yl)-1-nitro-1-ol]benzonitrile (I297), 5-[5-(2-chloro-1-pyridin-4-yl)-1-nitro-1-ol]benzonitrile (I298), 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (I299), 5-[5-(2-chloropyridin-4-yl)-1-nitro-1-ol]benzonitrile (I291), 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonit )-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (I294), 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamide (I295), 4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazole,

[0129] -2(5H)-one (I296), 4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one (I297), 4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one (I298), 4-{[(6-chloropyridin-3-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one (I299), Pyflubumide acaricide N-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropane-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H -pyrazole-4-carboxamide (I300), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylic acid (I301), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylic acid (I302), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylic acid (I303), 2-[3,5 -dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylic acid (I304), methyl 2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylic acid (I305), (5RS,7RS; 5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine (I306), 2-{6-[2-(5-fluoropyridin-3-yl)-1,3 -thiazol-5-yl]pyridin-2-yl}pyrimidine (I307), 2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine (I308), 1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide (I309), 1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide (I310),N-[2-(tert-Butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide (I311), N-[2-(tert-Butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide (I312), (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-(2,2-difluoroethyl)acetamide (I313), N-[2-(5-amino-1,3,4-thiadiazole-2-yl) -4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide (I314), 4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide (I314), methyl 2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylic acid (I315), and Agrigata, Amblyseiida genus, Aphidida, Aphidida, Aphid midge, Artimisinin, High-efficiency flucythrinate, Dimethoate, Bromothrin, Bromothion-e, Capsaicin, Dimethoate, Osthole, Aphidida, 2,6-dichlorophenolindoxyphenol (DCIP), Dichloropropylene, Mixed carb, Disulfide, Dodecyl acetate, Enphidida, Aphidida, Ethylene-dibromide, Eucalyptol, Flumethrin, Flumethrin, Anguo, Harmonia, Indole-3-ylbutyric acid, Isocarb, Isothiophos, Isothiophos-m, Isoprocarb, Leaf aphid, Lindane, Liuyangmycin, Matrine, Dimethoate, Metformin, Black Mushroom, Mirex, Metathiocyanate, Insecticidal Mono, Oleic acid, Small Flower Bug, Oxymatrine, Paecilomyces, Pasteur A1) carbamates, including aldicarb, benfuracarb, carbaryl, carbofuran, carbofuran, methoxychlor, methomyl, oxadiazine ...Chlorpyrifos-methyl, demeton-methyl, diazinon, dichlorvos / DDVP, dicrotophos, dimethoate, ethidium, ethion, fenitrothion, fenthion, oxazolidinone, malathion, methamidophos, methidathion, mefenphos, monocrotophos, omethoate, sulfoxide, parathion, methyl parathion, fenthion, phosphothion, parathion, methyl parathion, fenthion, phorate, phosalone, phosmet, phosphamidon, quinalphos, terbufos, chlorpyrifos, triazophos and trichlorfon; A3) cyclodiene organochlorine compounds, such as endosulfan; A4) butene fipronils, including ethidium, fipronil, pyrafluprole and pyriprole; A5) neonicotinoids, including acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; A6) spinosads, such as A7) chloride channel activators from pectins, including: abamectin, amanmectin, ivermectin, ivermectin, abamectin and imipenem; A8) juvenile hormone mimetics, such as methoprene, methoprene, methoprene, fenoxycarb and pyriproxyfen; A9) selective monoptera feed blockers, such as pymetrozine, flunicamide and flufenicol; A10) mite growth inhibitors, such as clofentezine, hexathiazolin and etoxazole; All) mitochondrial ATP synthase inhibitors, such as diafenthiuron, fenbutatin and propargite; oxidative phosphorylation decouplers, such as chlorfenapyr; A12) nicotinic acetylcholine receptor channel blockers, such as sulfamethoxam, baclofen, cypermethrin and dimethoate; A13) benzoyl Urea-type 0 chitin biosynthesis inhibitors, including: bistrifluan, chlorfenapyr, fluazifop, hexafluan, lufenuron, fluazifop and flubendiamide; A14) Class 1 chitin biosynthesis inhibitors, such as ibuprofen; A15) Molting disruptors, such as cyromazine; A16) Ecdysone receptor agonists, such as methoxyfenozide, fenpyroximate, chlorfenapyr and chlorfenapyr; A17) Octopamine receptor agonists, such as amitraz; A18) Mitochondrial complex electron transport inhibitors: pyraclostrobin, phosphine, zinc phosphide, pyrimidine, cypermethrin, fluazifop, hydrazone, acequinoxaline or pyrimidine; A19) Voltage-dependent sodium channel blockers, such as indoxacarb and cyanofluoride; A20) Lipid synthesis inhibitors, such as spirodiclofen and spiromesifen and spirotetramat; A21) diamide lonadan receptor modulators, including: flubendiamide, the phthalamide compounds ()-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide and (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide, chlorantraniliprole and cyantraniliprole; A22) compounds with unknown or uncertain modes of action: for example, azadirachtin, sulfamethoxam, bifenazate, fluthiazide, piperonyl butoxide, pyridalyl,Sulfone cypermethrin; or A23) sodium channel modulators of the pyrethroid class, including: flumethrin, allethrin, bifenthrin, cyfluthrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, cis-cypermethrin, ethomethrin, cypromethrin, cypermethrin, flucythrin, fluvalinate, permethrin, silafluthrin and tralomethrin, and combinations thereof.

[0130] In some embodiments, the plant treatment product comprises two or more (i.e., multiple) pesticides. For example, the plant treatment product may comprise a first pesticide, preferably selected from the above group, and a second pesticide, preferably selected from the above group, different from the first pesticide. Some embodiments may include, for example, a third pesticide, preferably selected from the above listed groups, and different from the first and second pesticides.

[0131] Exemplary Antimicrobial Pesticides

[0132] In some embodiments, the pesticide may be or comprise a (chemical) antimicrobial agent (e.g., an antibiotic, antiparasitic agent, antiviral agent, bactericide, fungicide, etc.). In some embodiments, one or more antimicrobial pesticides may be used to inhibit or destroy microorganisms present on plants or plant parts (fruits, flowers, leaves, stems, tubers or roots) of different crops of useful plants, providing protection (e.g., from fungal infections, plant pathogenic fungi in the soil, or plant pathogenic insects). Without being bound by any theory, the type of pathogen and the type of plant generally determine the type of active ingredient used to prepare the plant treatment product. Targeted pathogens include, but are not limited to, plant pathogenic fungi, such as Ascomycetes (e.g., Venturia, Formospora, Powdery Mildew, Sclerotinia, Mycosphaeria, Uncinaria); Basidiomycetes (e.g., Hemieia, Rhizoctonia, Puccinia; Imperfect Fungi (e.g., Botrytis, Helminthosporium, Rhizoctonia, Fusarium, Septoria, Cercospora, Alternaria, Pyricularia, and Pyrotrichum tritici); Oomycetes (e.g., Phytophthora, Peronospora, Discoideum, Pythium, Monoparata), Take-all Pseudomonas aeruginosa (all classes), Blumeria graminis (molds). Plant types include, but are not limited to varieties of soybean, wheat, rice, corn (or maize), barley, oats, peas, hay (or alfalfa), tomato, potato, avocado, and other crop (and non-crop) plants.

[0133] In some embodiments, pesticide can be or comprise one or more (synthetic) chemicals, molecules or compounds, or a mixture of two or more (synthetic) chemicals, molecules or compounds. A variety of (chemical) antimicrobial pesticides are commercially available and known to those skilled in the art, each of which is contemplated herein.

[0134] Exemplary fungicides

[0135] In some embodiments, the pesticide may be or comprise a (chemical) fungicide. A variety of (chemical) fungicides are commercially available and known to those skilled in the art, each of which is contemplated herein. Exemplary (chemical) fungicides include, but are not limited to, azoles, such as fluquinconazole (Agrevo), cyproconazole (Novartis), penconazole (Rhone-Poulenc), phenylpyrroles, such as fenthionil or flutolanil (both from Novartis), and other structural types, such as decanamide, thiabendazole, methylamine (both from Bayer AG), and strobilurins (BASF AG), such as myclobutanil. (Chemical) fungicides or their active ingredients (ai) have different trade names, for example, for wheat, methylamine is Or for rice, decylamide is Contains carboxin and thiram for treating wheat, barley and oat seeds. Protects against Septoria, mold or anything else. Tebuconazole is Further examples are given by product suppliers, for example through the catalogue of Gustavson Inc. (http: / / www.gustafson.com / ).

[0136] According to one embodiment of the present disclosure, the preferred fungicide is selected from: one or more (1) ergosterol biosynthesis inhibitors, such as (F1) dimethylmorpholine (1704-28-5), (F2) azaconazole (60207-31-0), (F3) triaconazole (55179-31-2), (F4) oxadiazol (116255-48-2), (F5) cyproconazole (113096-99-4), (F6) triaconazole (75736-33-3), (F7) difenoconazole (119446-68-3), (F8) diniconazole (83657-24-3), (F9) diniconazole-M (83657-18-5), (F10) dodecacyclic morpholine chlorpyrifos (1593-77-7), (F11) chlorpyrifos acetate (31717-87-0), (F12) epoxiconazole (106325-08-0), (F13) ethiconazole (60207-93-4), (F14) chlorfenapyr (60168-88-9), (F15) fenbuconazole (114369-43-6), (F16) fenhexamid (126833-17-8), (F17) fenpropidin (67306-00-7), (F18) fenpropimorph (67306-03-0), (F19) fluquinconazole (136426-54-5), (F20) furamidol (56425-91-3), (F21) flusilazole (855 09-19-9)、(F22) fluconazole(76674-21-0)、(F23) furconazole(112839-33-5)、(F24) cis-fuconazole(112839-32-4)、(F25) hexaconazole(79983-71-4)、(F26) imazalil(60534-80-7)、(F27) imazalil sulfate(58594-72-2)、(F28) imipenem(86598-92-7)、(F29) cyproconazole standard(125225-28-7)、(F30) metconazole(125116-23-6)、(F31) myclobutanil(88671-89-0)、(F32) naftifine(65472 -88-0)、(F33) flufenamic acid (63284-71-9)、(F34) fumaric acid oxadiazine (174212-12-5)、(F35) paclobutrazol (76738-62-0)、(F36) pyrimethamine (101903-30-4)、(F37) penconazole (66246-88-6)、(F38) powder disease lin (3478-94-2)、(F39) prochloraz (67747-09-5)、(F40) propiconazole (60207-90-1)、(F41) prothioconazole (178928-70-6)、(F42) barnyardgrass (88678-67-5)、(F43) pyrimidine oxime (88283-41-4)、(F44) oxazolidinone (103970-75-8), (F45) siloxane (149508-90-7), (F46) spiroxazoline (118134-30-8), (F47) tebuconazole (107534-96-3), (F48) terbinafine hydrochloride (91161-71-6), (F49) tetraconazole (112281-77-3), (F50) triadimefon (43121-43-3), (F51) triadimenol (89482-17-7), (F52) chlorpyrifos (81412-43-3), (F53) triflumizole (68694-11-1), (F54) triflumizole (26644-46-2), (F55) sterilization azole (131983-72-7), (F56) chlorconazole (83657-22-1), (F57) chlorconazole-p (83657-17-4), (F58) cloconazole hydrochloride (77174-66-4), (F59) voriconazole (137234-62-9), (F60) 1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl) cycloheptanol (129586-32-9), (F61) 1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylic acid methyl ester (110323-95-0), (F62) N'-{5-(difluoromethyl)-2-methyl-4-[3-(N-trimethyl)- (F63) N-ethyl-N-methyl-N'-{2-methyl-5-(trifluoromethyl)-4-[3-(N-trimethylsilylacetamide)propoxy]phenyl}imidocarboxamide, (F64) 0-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]1H-imidazole-1-carbosulfate (111226-71-2); (2) inhibitors of respiratory chain complex I or II, such as (F65) bixafen (581809-46-3), (F66) boscalid (188425-85-6), (F67) carboxin (5234-68-4), (F68) dimethomorph (5412-70-6), (F69) pyraclostrobin (5412-70-6), (F70) pyraclostrobin (5412-70-6), (F71) pyraclostrobin (5412-70-6), (F72) pyraclostrobin (5412-70-6), (F73) pyraclostrobin (5412-70-6), (F74) pyraclostrobin (5412-70-6), (F75) pyraclostrobin (5412-70-6), (F76) pyraclostrobin (5412-70-6), (F77) pyraclostrobin (5412-70-6), (F78) pyraclostrobin (5412-70-6) Fluorine (130339-07-0), (F69) furamide (24691-80-3), (F70) fluopyram (658066-35-4), (F71) flutolanil (66332-96-5), (F72) flubendiamide (907204-31-3), (F73) furopyram (123572-88-3), (F74) seed dressing amine (60568-05-0), (F75) pyraclostrobin (mixture of cis-diameric racemates 1RS, 4SR, 9RS and trans-diameric racemates 1RS, 4SR, 9SR) (881685-58-1), (F76) pyraclostrobin (trans-diameric racemates 1RS,4SR, 9SR), (F77) pyraclostrobin (trans epimeric enantiomers 1R, 4S, 9S), (F78) pyraclostrobin (trans epimeric enantiomers 1S, 4R, 9R), (F79) pyraclostrobin (cis epimeric racemates 1RS, 4SR, 9RS), (F80) pyraclostrobin (cis epimeric enantiomers 1R, 4S, 9R), (F81) pyraclostrobin (cis epimeric enantiomers 1S, 4R, 9S), (F82) oxadiazine (55814-41-0), (F83) oxadiazine (5259-88-1), (F84) trifloxystrobin (494793-67-8), (F85 ) penthiopyrad (183675-82-3), (F86) fluazifop (874967-67-6), (F87) thiofuran (130000-40-7), (F88) 1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (F89) 3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide, (F90) 3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide, (F91 )N-[1-(2,4-dichlorophenyl)-1-methoxypropane-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (1092400-95-7), (F92) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinolin-4-amine (1210070-84-0), (F93) benzovinflumizone, (F94) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylnaphthylene-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (F95) N-[(1R, (F96) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (F97) 1,3,5-trimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (F98) 1-methyl-3-(trifluoromethyl)-N-(1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide,(F99) 1-methyl-3-(trifluoromethyl)-N-[(1S)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (F100) 1-methyl-3-(trifluoromethyl)-N-[(1R)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (F101) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (F102) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl methyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (F103) 1,3,5-trimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (F104) 1,3,5-trimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide; (3) inhibitors of respiratory chain complex III, for example, (F105) azoxystrobin (865318-97-4), (F106) anbisulfite (348635-87-0), (F107) myclobutanil (1 31860-33-8)、(F108) cyazofamid (120116-88-3)、(F109) cypermethrin (850881-30-0)、(F110) syringostyrin (850881-70-8)、(F111) kystrobin (141600-52-4)、(F112) oxathiapiprolin (238410-11-2)、(F113) oxathiapiprolin (131807-57-3)、(F114) fenamidone (161326-34-7)、(F115) cypermethrin (918162-02-4)、(F116) fluoxastrobin (361377-29-9)、(F117) kystrobin (1 43390-89-0)、(F118) (E)-benoxamyl (133408-50-1)、(F119) orysastrobin standard (189892-69-1)、(F120) picoxystrobin (117428-22-5)、(F121) pyraclostrobin (175013-18-0)、(F122) oxadiazon (915410-70-7)、(F123) pyraclostrobin (862588-11-2)、(F124) pyraclostrobin (799247-52-2)、(F125) chlorpyrifos solution (902760-40-1)、(F126) trifloxystrobin (141517-21-7)、(F127) (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylacetamide, (F128)-2-(methoxyimino)-N-methylacetamide, (F128) (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)acetamide, (F129) (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}acetamide (158169) -73-4), (F130) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide (326896-28-0), (F131) (2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)-3-butene-2-ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (F132) 2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide (119899- 14-8), (F133) 5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, (F134) (2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulfanyl)methyl]phenyl}-3-methoxyprop-2-hexenoic acid methyl ester (149601-03-6), (F135) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide (226551-21-9), (F136) 2-{2-[(2,5-dihydro-3H-1,2,4-triazol-3-one (F137) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide (173662-97-0), (F137) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide (394657-24-0); (4) inhibitors of mitosis and cell division, for example, (F138) benomyl (17804-35-2), (F139) carbendazim (10605-21-7), (F140) 2-(2-chlorophenyl)-1H-benzimidazole (3574-96-7), (F141) ethofluthrin (87130-20-9), (F142) haloperidol (162650-77-3),(F143) Fluobosaccharid (239110-15-7), (F144) Triflumuron (3878-19-1), (F145) Pencycuron (66063-05-6), (F146) Thiabendazole (148-79-8), (F147) Methylthiophanate (23564-05-8), (F148) Thiophanate (23564-06-9), (F149) Zoxamidin (156052-68-5), (F150) 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine (214706-53-3), (F151) 3-chloro-5-(6-chloropyridine) (5) Compounds capable of multi-site action, for example, (F152) Bordeaux mixture (8011-63-0), (F153) captamipan (2425-06-1), (F154) captan (133-06-2), (F155) thiophanate-methyl (1897-45-6), (F156) cupric hydroxide (20427-59-2), (F157) cupric cyclohexane (1338-02-9), (F158) cuprous oxide (1317-39-1), (F159) basic cupric chloride (1332-40-7), (F160) cupric sulfate (7758-98-7), (F161) dichlorvosine (1085-98-9), (F162) dicyanoanthraquinone (3347-22-6), (F163) dodine (2439-10-3), (F164) dodine free base, (F165) ferbam (14484-64-1), (F166) N-phthalimide (719-96-0), (F167) folpet (133-07-3), (F168) biguanide salt (108173-90-6), (F169) biguanide acetate, (F169) biguanide acetate, (F170) biguanide octylamine (13516-27-3), (F171) alkylbenzene sulfonate standard (16 9202-06-6)、(F172) Biguanidine triacetate (57520-17-9)、(F173) Mancozeb (53988-93-5)、(F174) Mancozeb (8018-01-7)、(F175) Maneb (12427-38-2)、(F176) Methanide (9006-42-2)、(F177) Methanide zinc (9006-42-2)、(F178) 8-Hydroxyquinoline copper (10380-28-6)、(F179) Propamidine (104-32-5)、(F180) Propineb (12071-83-9)、(F181) Sulfur and sulfur preparations including calcium polysulfide (7704-34-9)、(F182) Thiram (137-26-8), (F183) Tolylfluanid (731-27-1), (F184) Mancozeb (12122-67-7), (F185) Thiram (137-30-4); (6) Compounds capable of inducing host defense, for example, benzothiadiazole (135158-54-2), (F187) Isothiazolin (224049-04-1), (F188) Propylenethiocarb (27605-76-1), (F189) Thiacandil (223580-51-6); (7) Inhibitors of amino acid and / or protein biosynthesis, for example, (F190) Amine (23951-85-1), (F191) Blasticidin ( 2079-00-7), (F192) cyprodinil (121552-61-2), (F193) kasugamycin (6980-18-3), (F194) kasugamycin hydrochloride hydrate (19408-46-9), (F195) myclobutanil (110235-47-7), (F196) myclobutanil (53112-28-0), (F197) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline (861647-32-7); (8) ATP production inhibitors, for example, (F198) triphenyltin acetate (900-95-8), (F199) triphenyltin chloride (639-58-7), (F190) 200) triphenyltin hydroxide (76-87-9), (F201) silthiopyrad (175217-20-6); (9) cell wall synthesis inhibitors, for example, (F202) benzathiapiprolin (177406-68-7), (F203) oxadiazine (110488-70-5), (F204) flumorph (211867-47-9), (F205) propineb (140923-17-7), (F206) dimethomorph (374726-62-2), (F207) polyoxin (11113-80-7), (F208) balamin (22976-86-9), (F209) jinggangmycin (37248-47-8), ( F210) Downy mildew killer (283159-94-4; 283159-90-0); (10) lipid and membrane synthesis inhibitors, for example, (F211) biphenyl (92-52-4), (F212) dichlorvos (2675-77-6), (F213) chloranil (99-30-9), (F214) chloranil (17109-49-8), (F215) thiabendazim (2593-15-9), (F216) iodopropynyl butylcarbamate (55406-53-6), (F217) isothiocyanate (26087-47-8), (F218) pyraclostrobin (50512-35-1), (F219) cymoxanil (25606-41-1),(F220) propamocarb hydrochloride (25606-41-1), (F221) thiocarb (19622-08-3), (F222) cyfluthrin (13457-18-6), (F223) pentachloronitrobenzene (82-68-8), (F224) tetrachloronitrobenzene (117-18-0), (F225) methyl tolclofos (57018-04-9); (11) melanin biosynthesis inhibitors, for example, (F226) cyproconazole (104030-54-8), (F227) dichlorocyanamide (139920-32-4), (F228) cyanamide (115852-48-7), (F229) tetrachlorophthalide (27355- 22-2), (F230) praziquantel (57369-32-1), (F231) tricyclazole (41814-78-2), (F232) 2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate (851524-22-6); (12) nucleic acid synthesis inhibitors, for example, (F233) bensulfuron (71626-11-4), (F234) bensulfuron-methyl (98243-83-5), (F235) ethoxybenzyl sulfonate (41483-43-6), (F236) clozylacon (67932-85-8), (F237) dimethoxybenzyl (5221-53 -4), (F238) ethidium bromide (23947-60-6), (F239) furalaxyl (57646-30-7), (F240) oxadixyl (10004-44-1), (F241) metalaxyl (57837-19-1), (F242) metalaxyl-M (70630-17-0), (F243) furamide (58810-48-3), (F244) oxadixyl (77732-09-3), (F245) oxolinic acid (14698-29-4); (13) signal transduction inhibitors, for example, (F246) oxadixyl (84332-86-5), (F247) fenpiclonil (74738-17-3), (F248 ) fluazifop-butyl (131341-86-1), (F249) isoprodinil (36734-19-7), (F250) procymidone (32809-16-8), (F251) quinoxyfen (124495-18-7), (F252) vinclozolin (50471-44-8); (14) compounds that can act as uncouplers, for example, (F253) binacarb (485-31-4), (F254) diclofenac (131-72-6), (F255) pyrimidine (89269-64-7), (F256) fluazifop-butyl (79622-59-6), (F257) diclofenac (131-72-6); (15) other compounds, for example,(F258) benzothiocyanate (21564-17-0), (F259) 3-benzo[b]thiophen-2-yl-5,6-dihydro-1,4,2-thiazine 4-oxide (163269-30-5), (F260) carbamicin (70694-08-5), (F261) carvone (99-49-0), (F262) chloranil (2439-01-2), (F263) chloranil (688046-61-9), (F264) thiocyanate (11096-18-7), (F265) flutolanil (180409-60-3), (F266) cymoxanil (57966-95-7), (F267) bosacralase Amine (221667-31-8), (F268) dazomethane (533-74-4), (F269) imidacloprid (62732-91-6), (F270) dichlorophen (97-23-4), (F271) dazomethane (62865-36-5), (F272) cypermethrin (49866-87-7), (F273) cypermethrin dimethyl sulfate (43222-48-6), (F724) diphenylamine (122-39-4), (F275) ecomate, (F276) pyraclostrobin (473798-59-3), (F277) fluazifop (154025-04-4), (F278) fluoroimide (41205-21 -4)、(F279) sulfamethoxazole (106917-52-6)、(F280) flutianil (304900-25-2)、(F281) phosphoenol (39148-24-8)、(F282) fosetyl calcium、(F283) fosetyl sodium (39148-16-8)、(F284) hexachlorobenzene (118-74-1)、(F285) human mycin (81604-73-1)、(F286) sulfamethoxazole (66952-49-6)、(F287) methyl isothiocyanate (556-61-6)、(F288) mefenamic acid (220899-03-6)、(F289) midotoxin (67527-71-3)、 (F290) Natamycin (7681-93-8), (F291) Nickel dimethylaminodithiocarboxylate (15521-65-0), (F292) Phthalostrobin (10552-74-6), (F293) N-octylisothiazolinone (26530-20-1), (F294) oxamocarb (917242-12-7), (F295) Oxofenzene (34407-87-9), (F296) Pentachlorophenol and its salts (87-86-5), (F297) Phenothrin, (F298) Phosphorous acid and its salts (13598-36-2), (F299) Cymoxanil ethanoate, (F300) Sodium propane octyldodecyl (88498-02-6),(F301) Propoxyquinoline (189278-12-4), (F302) Butylpyroximate (868390-90-3), (F303) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)-prop-2-en-1-one (1231776-28-5), (F304) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)-prop-2-en-1-one (1231776-29-6), (F305) Nitropyrrolidone (1018-71-9), (F306) Tefoquinoline (376645-78-2 )、(F307) chloranil (76280-91-6), (F308) mesotrione (304911-98-6), (F309) imidazobactam (72459-58-6), (F310) salicylate (70193-21-4), (F311) cyfluthrin (84527-51-5), (F312) (3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonane-7-2-propionic acid methyl ester (517875-34-2), (F313) 1-(4-{4-[ (5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1003319-79-6), (F314) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1003319-80-9), (F315) 1-(4-{4-[5-(2,6 -difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1003318-67-9), (F316) 1-(4-methoxyphenoxy)-3,1H-imidazole-1-carboxylic acid 3-dimethylbutane-2-carboxylate (111227-17-9), (F317) 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine (13108-52-6), (F318) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one (221451-58-7),(F319) 2,6-dimethyl-1H,5H-[1,4]dithiohexane[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone, (F320) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (1003316-53-7), (F321) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2- oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (1003316-54-8), (F322) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone (1003316-51-5), (F323) 2-butoxy-6-iodo-3-propyl-4H-benzopyran-4-one, (F324) 2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine, (F32 5) 2-phenylphenol and salts (90-43-7), (F326) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline (861647-85-0), (F327) 3,4,5-trichloropyridine-2,6-dicarbonitrile (17824-85-0), (F328) 3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine, (F329) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (F330) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (F3 31) 5-amino-1,3,4-thiadiazole-2-thiol, (F332) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonylhydrazide (134-31-6), (F333) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine (1174376-11-4), (F334) 5-fluoro-2-[[(4-methylbenzyl)oxy]pyrimidin-4-amine (1174376-25-0), (F335) 5-methyl-6-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, (F336) (2Z)-3-amino-2-cyano-3-cyano-3-phenylprop-2-enoic acid ethyl ester,(F337) N'-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarboxamide, (F338) N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propionamide, (F339) N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propionamide, (F340) N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide, (F341) N-[1-(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide 1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide, (F343) N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide (221201-92-9), (F344) N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide (221201-92-9), (F345) N'-{4-[(3-tert-butyl-4-cyano-1, 2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methyliminocarboxamide, (F346) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide (922514-49-6), (F347) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide (922514 -07-6)、(F348) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide (922514-48-5)、(F349) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamic acid pentyl ester、(F350) phenazine-1-carboxylic acid、(F351) quinolin-8-ol(134-31-6)、(F352) quinolin-8-ol sulfate (2:1)(134-31-6)、(F353) tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate; (16) other compounds, for example, (F354) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (F355) N-(4'-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (F356) N-(2-',4'-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (F357) 3-(difluoromethyl)- 1-methyl-N-[4'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (F358) N-(2-',5'-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (F359) 3-(difluoromethyl)-1-methyl-N-[4'-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (F360) 5-fluoro-1,3-dimethyl-N-[4'-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (F361) 2-chloro-N-[4'-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3- Formamide, (F362) 3-(difluoromethyl)-N-[4'-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (F363) N-[4'-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, (F364) 3-(difluoromethyl)-N-(4-'-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide, (F365) N-(4'-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, (F366) 2-chloro-N-( 4-'-ethynylbiphenyl-2-yl)pyridine-3-carboxamide, (F367) 2-chloro-N-[4'-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, (F368) 4-(difluoromethyl)-2-methyl-N-[4'-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide, (F369) 5-fluoro-N-[4'-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, (F370) 2-chloro-N-[4'-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(F371) 3-(Difluoromethyl)-N-[4'-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (F372) 5-Fluoro-N-[4'-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, (F373) 2-Chloro-N-[4'-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, (F374) (5-Bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone, (F375) N-[2 -(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl}-3-methoxyphenyl)ethyl]-N2-(methylsulfonyl)valinamide (220706-93-4), (F376) 4-oxo-4-[(2-phenylethyl)amino]butyric acid, (F377) but-3-yn-1-yl {6-[{[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (F378) 4-amino-5-fluoropyrimidin-2-ol (mesomeric form: 6-amino-5-fluoropyrimidin-2(1H)-one), (F379) propyl 3,4,5-trihydroxybenzoate and (F380) oxadiazine.

[0137] Other fungicides include solatenol dehydrogenase inhibitors (SDHI) pyrazole-carboxamides of fungicides. Examples include phenyl-benzamides, phenyl-oxo-ethylthiophene amides, pyridinyl-ethyl-benzamides, furan-carboxamides, oxathiin-carboxamides, thiazole-carboxamides, pyrazole-carboxamides, pyridine-carboxamides, and combinations thereof.

[0138] Exemplary herbicides

[0139] In some embodiments, the pesticide can be or include a (chemical) herbicide. A variety of (chemical) herbicides are commercially available and known to those skilled in the art, each of which is covered herein. Exemplary (chemical) herbicides include, but are not limited to: C1) acetyl-CoA carboxylase inhibitors (ACC), such as cyclohexenone oxime ethers, such as cypermethrin, chlorpyrifos, cyclohexenone, cyclohexane, sethoxydim, trimethylolpropane, cyproconazole, or pyraclostrobin; phenoxyphenoxypropionates, such as cyhalofop-butyl, cyfluthrin, dimethoate, oxadiazine, oxadiazine, thiamethoxam, fluazifop-butyl ... or aromatic aminopropionic acids, such as methyl cypermethrin or isopropyl cypermethrin; C2) acetolactate synthase inhibitors (ALS), for example, imidazolinones, such as imazapyr, imazaquin, imazapyr, imazamox, or imazapyr; pyrimidine ethers, such as sulfamethoxam, sulfamethoxam sodium, and bispyribac-butyl. KIH-6127 or benzyloxypyrimidine; sulfonamides such as bispyribac, fluazifop or fluazifop; or sulfonylureas such as amidosulfuron-methyl, tetrazosulfuron-methyl, benzylsulfuron-methyl, chlorimuron-methyl, chlorsulfuron-methyl, ethoxysulfuron-methyl, flazasulfuron-methyl, chlorpyrisulfuron-methyl, pyrazosulfuron-methyl, metsulfuron-methyl, nicosulfuron, primisulfuron-methyl, prosulfuron-methyl, pyrazosulfuron-methyl, sulfasulfuron-methyl, sulfasulfuron-methyl, thifensulfuron-methyl, ethoxysulfuron-methyl, bensulfuron-methyl, bensulfuron-methyl, fluamide C3) amides, such as CDAA, chloranil, bromobutyric acid, chlorsulfuron, benzylpyridinium, benzchlomet, thiamethoxam, cypermethrin or heptanoylpyridinium; C4) auxin herbicides, such as pyridine carboxylic acids, such as clopyralid or amiloride; or 2,4-D or chloranil; C5) auxin transfer inhibitors C6) carotenoid biosynthesis inhibitors, for example, pyraclostrobin, isoxadiazole, pyrifosamide, fluazifop, flupyrad, pyrazoline, benzylpyridin, isoxadiazole, isoxadiazole, mesotrione, chlormesulone, cyclohexanedione, furazolidone, norfadone, aminotriazole; C7) enolpyruvylshikimate-3-phosphate synthase inhibitors (EPSPS), for example, glyphosate or oxadiazole Sulfonium phosphine; C8) glutamine synthetase inhibitors, for example bialaphos or glufosinate; C9) lipid biosynthesis inhibitors, for example anilides, such as thiamethoxam or mefenacet; acetylchloroanilides, such as dimethinamid, S-dimethinamid, acetochlor, alachlor, butachlor, butenesulfonamide, acetochlor, dimethinamid, pyraclostrobin, isopropyl metolachlor, S-isopropyl metolachlor, pretilachlor, pyraclostrobin, propargyl sulfoxide, terbutaline, dimethinamid or dimethinamid;Thioureas, such as butachlor, cyclopropane, avenachlor, piperocarb, cypermethrin, pentocarb, gramineous, chloranil, benthiocarb, benthiocarb, wild wheat dapoxetine or chloranil; or - furocarb or yellow grass dapoxetine; C10) mitotic inhibitors, for example - carbamates, such as sulfamethoxazole, carbamate, chlorpropane, chloranil, propyzamid, chloranil or chloranil; dinitroanilines, such as fluazifop, butachlor, aminofluanid, ethofluanid, chloranil, amoxicillin, pendimethalin, aminofluanid or trifluanid; - pyridines, such as dithiopyr or thiathiocarb, or - phosphinothion , dichlorvos (DCPA) or cypermethrin; C11) protoporphyrinogen IX oxidase inhibitors, for example diphenyl ethers, such as acifluorfen, acifluorfen sodium, beniflox, carbofuran, chlorpyrifos (CNP), flurandrenoyl, trifluorfen, fluazifop-butyl, fomesafen, flusulfuron, lactofen, nitropropane, trifluorfen, trifluorfen, trifluorfen, trifluorfen or oxyfluorfen; diazoles, such as oxadiazine or oxadiazine; cyclic imides, such as fluazifop-butyl, fluazifop-butyl, fluazifop-butyl, indolepyralid, flufenac, flufenac, chlorpyrifos, flumipropyn, flupropacil, flufenac-methyl , sulfentrazone or dimethoate; or pyrazoles, such as ET-751, JV485 or fluazifop; C12) photosynthesis inhibitors, for example, propanil, pyridazinol or pyridazinol; benzothiadiazinones, such as bentazone; dinitrophenols, for example, bromophenol, dinoseb, dinoseb, teroseb or dinitrophenol; dipyridinyl subunits, such as chloranil chloride, diquat, diquat or paraquat dichloride; ureas, such as chlorbromid, chlorotoluron, chloranil, azole, diuron, sulfathiocarb, fenitrocarb, fluuron, isoproturon, isoxuron, linuron, methylbenzene, chloranil, pyranuron, methoxythiocarb, chloranil, chloranil, cypermethrin or butadiene chloranil; triazines such as ametryn, atrazine, cyanazine, dichlorvos, isopentanol, hexazinone, promethazine, promethazine, simazine, simethoxam, terbutaline, terbutaline, terbuthion or terbuthion; triazinones such as metamitron or metribuzin; uracils such as bromocriptine, cypermethrin or terbacil; or biscarbamates such as betamethrin or betamethin; C13) synergists, for example oxiranes such as chloranil; C16 various other herbicides, for example dichloropropionic acids such as dalapon; dihydrobenzofurans such as ethoxyfuroxan; phenylacetic acids such as fenac;or azido, avenaline, dimethoate, benzylthiocarb, fluazifop, buminafos, butylthiocarb, bromothiocarb, chloranil, avenaline, chloranil, cyproconazole, cyproconazole, cyproconazole, dibenzyluron, isopropyl, tiaclostrobin, eglinazin-ethyl, endosulfan, ethidium, flucabazone, fluorbentranil, fluazifop, tiaclostrobin, isopropyl, cyproconazole, cyproconazole, oxaciclomethazine ...

[0140] In a preferred embodiment, the herbicide may be or comprise glyphosate (N-(phosphonomethyl)glycine).

[0141] Exemplary Plant Growth Regulators (PGRs)

[0142] In some embodiments, the plant treatment component can be or include one or more PGRs. A variety of PGRs are commercially available and known to those skilled in the art, each of which is contemplated herein. Exemplary PGRs include, but are not limited to: D1) anti-auxins, such as clofibric acid, 2,3,5-triiodobenzoic acid; D2) auxins, such as 4-CPA, 2,4-D, 2,4-DB, 2,4-DEP, dichlorvos, 2,4,5-trichloropropionic acid, IAA, IBA, naphthylacetamide, α-naphthol, naphthoxy; D3) cytokinins, such as 2iP, benzyl adenine, 4-hydroxyphenylethanol, kinetin, zeatin; D4) defoliants, such as Calcium cyanamide, metformin, endorphin, ethephon, defoliant phosphorous, methoxuron, pentachlorophenol, thidiazuron, defoliant phosphine; D5) ethylene inhibitors, such as α-glycine, 1-methylcyclopropene; D6) ethylene releasers, such as ACC, acetylsalicylic acid, ethephon, glyoxime; D7) gametocides, such as fenhexamid, maleic hydrazide; D8) gibberellins, such as gibberellin, gibberellic acid; D9) growth inhibitors, such as abscisic acid, cyprodinil, butenyl formic acid, carbaryl, tributyl chlorobenzylphosphine , chlorpromazine, dikegulac, flumethoxam, flutolanil, phosphoramide, glycylphosphine, isopromazine, jasmonic acid; D10) morpholine herbicides, such as chlorpyrifos, chlorpyrifos, dichlorpyrifos, flutolanil; D11) growth retardants, such as chlormequat, butyric acid hydrazide, fluazifop, flusulfuron, paclobutrazol, tetracyclazole, uniconazole; D12) growth stimulants, such as brassinolide, brassinolide-ethyl ester, DCPTA, chlorpyrifos, oxazolidinone, psoralen, trithione Alkanols; D13) Plant growth regulators not classified, for example, chrysanthemum ethyl, fluazifop, bufinafos, carvone, choline chloride, ciobutide, androzine acid, cyanamide, cycloheximide, cycloheximide, cyclopropylsulfonamide, propionyl brassinolide, indole ester, ethylene, furanthiocarb, glycol acetal, yield-increasing oxime, perfluorosulfonamide, antineptazone, karetazan, lead arsenate, sulfamethoxam, prohexadione, pyrone, thiamethoxam, thiamethoxam, and combinations thereof.

[0143] Other exemplary components

[0144] Some embodiments of the present disclosure may include one or more additional components and / or ingredients.

[0145] For example, embodiments further include one or more of the following: (1) amino acids, (2) peptides, (3) hydrolyzed proteins, (4) organic acids and / or carboxylic acids, (5) carbohydrates, (6) plant extracts, (7) lignin sulfonates, (8) humic acid and / or fulvic acid, (9) macronutrients, subnutrients and / or micronutrients, (10) chelated minerals and / or complex minerals, (11) vitamins, (12) wetting agents, (13) dispersants, and (14) surfactants. Some embodiments may also include one or more diluents or diluents. The one or more diluents or diluents may dilute one or more product components. The one or more diluents or diluents may also or alternatively provide a more uniform distribution of the plant treatment agent.

[0146] Some embodiments of the present disclosure may include one or more additional (supplementary) components and / or ingredients. For example, embodiments may include one or more vitamins (e.g., vitamin A, vitamin B complex (e.g., vitamin B 1 , Vitamin B 2 , Vitamin B 3 , Vitamin B 4 , Vitamin B 5 , Vitamin B 6 , Vitamin B 7 , Vitamin B 8 , Vitamin B 9 , Vitamin B 12 , choline), vitamin C, vitamin D, vitamin E, vitamin K, etc.), minerals or trace minerals (or elements) (e.g., magnesium, calcium, phosphorus, potassium, sodium, boron, cobalt, chloride, chromium, copper, fluoride, iodine, iron, manganese, molybdenum, selenium, zinc, nickel, vanadium, silicon, tin, etc.), amino acids (e.g., essential and / or non-essential), nutraceuticals (e.g., glucosamine, chondroitin, etc.), drugs (e.g., chemical additives, etc.), health foods, plants or plant matrix structures (e.g., berries, leaves, stems, roots, buds, seedlings, cotyledons, etc.), plant products or plant extracts (seaweed, algae or other extracts), herbs, phytonutrients, carotenoids, enzymes (e.g., amylase, xylanase, protease, phytase, glucanase), probiotics, organic acids, etc. Certain embodiments may be substantially and / or completely free of one or more variants of probiotics and / or live microorganisms.

[0147] Certain embodiments may include one or more surfactants, such as binders and / or emulsifiers (e.g., tartaric acid esters of mono- and di-glycerides, edible fats and oils, edible fat-forming fatty acids, ethoxylated mono- and di-glycerides, methyl glucoside coconut oil esters, mineral oil, mono- and di-glycerides of edible fats or oils or edible fat-forming acids, disodium phosphate derivatives of mono- and di-glycerides of edible fats or oils or edible fat-forming fatty acids, polyoxyethylene glycol 400 (mono- and dioleates), polysilicone, polysorbate 80, polysorbate 60 (polyoxyethylene (20)), sorbitan monostearate, propylene glycol, sodium stearoyl lactylate, sorbitan monostearate with or without polysorbate 60, and the like, or combinations thereof.

[0148] Some embodiments may include one or more stabilizers, anti-caking agents and / or processing agents (e.g., carrageenan, gelatin, guar gum, lecithin, locust bean gum, stearic acid, sodium carboxymethylcellulose, sodium aluminosilicate, tara gum, xanthan gum, etc.), dusting agents (e.g., mineral oil, paraffin, etc., or a combination of two or more of the foregoing), preservatives and / or other beneficial ingredients, or combinations thereof.

[0149] Some embodiments may also include one or more diluents or diluents. The one or more diluents or diluents may dilute the one or more products into a mixture. The one or more diluents or diluents may also or alternatively provide a more uniform distribution of the product or supplement components in the mixture. Exemplary diluents or diluents may include, but are not limited to, water or other aqueous solutions, a mixture of vitamins and / or minerals, an initial portion of a plant treatment component, an earth carrier, or any other suitable product or supplement component dilution or distribution element.

[0150] Exemplary Combination Products

[0151] As used herein, "combination product" and similar terms refer to a composition, mixture or other combination (e.g., reaction product) comprising at least a plant treatment component and a microbial fermentation product. For example, a combination product can be, contain or include a plant treatment component, a microbial fermentation product, an optional carrier (e.g., to which the microbial fermentation product is applied) and one or more optional other ingredients (e.g., vitamins, minerals or trace minerals, amino acids, health products, drugs, health foods, plants or plant matrix structures, plant products or plant extracts, herbs, phytonutrients, carotenoids, enzymes, probiotics, organic acids) and / or any other suitable additives or other components as described above. Certain embodiments may be substantially and / or completely free of one or more probiotics and / or live microorganisms.

[0152] In at least one embodiment, the combined plant treatment product comprises a microbial fermentation product, and is preferably mixed or combined with a substantially liquid plant treatment component, the fermentation product to plant treatment component preferably being mixed in a ratio of about 1:1 to about 1:100, or vice versa. In some embodiments, the ratio of fermentation product to plant treatment component, or vice versa, can be up to, between and / or about 1:1, 1:2, 1:2.5, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10 or more.

[0153] In some embodiments, the plant treatment product can be premixed as a combination product. In some embodiments, the combination product can include a concentrate. In at least one embodiment, the combination product can be diluted (e.g., with water) to form a ready-to-use product. In certain embodiments, the product can be mixed or premixed (e.g., mixed with a tank) at the time of application or to be applied (e.g., in the field). In some embodiments, the mixture can be or include a suspension, an emulsion, a solution, etc.

[0154] In one or more embodiments, the mixture or combination product can be stabilized, preferably by (1) adjusting the pH of the mixture to about pH 5-7, (2) adding one or more (chemical, synthetic, natural, organic) stabilizers, (3) adding or co-formulating with water and / or an organic mineral oil base, (4) encapsulating the mixture, etc. In some embodiments, the pH of the mixture can be adjusted to about pH 5, 5.5, 6, 6.5 or 7, if necessary.

[0155] One or more alternative or additional embodiments of the combination product comprises a substantially dry fermentation product (e.g., bound to a (solid or dry) carrier) and a substantially dry plant treatment component, the ratio of the carrier bound to the fermentation product to the plant treatment component preferably being between about 1:1 and about 1:100. In some embodiments, the ratio of the fermentation product to the plant treatment component, or vice versa, can be up to, between and / or about 1:1, 1:2, 1:2.5, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10 or more.

[0156] Some embodiments may include mixing a fermentation product in dry (powder) form (e.g., bound to a (solid or dry) carrier) and a plant treatment component. Certain embodiments may include grinding the carrier and plant treatment component bound to the fermentation product to the same or similar particle size. In some embodiments, the (dry form) combination product may be water-soluble, water-miscible, and / or (chemically and / or structurally) configured to produce a stable suspension (e.g., when mixed with an aqueous fluid (e.g., water)).

[0157] method

[0158] At least one embodiment includes a method for producing a plant treatment product, the method comprising providing a plant treatment component and mixing the plant treatment component with a microbial fermentation product. An exemplary method for producing a plant treatment product comprises combining a substantially liquid microbial fermentation product with a plant treatment component, preferably in a ratio of about 1:1 to about 1:100, adding the fermentation product to the plant treatment component for combination, or combining the plant treatment component with the fermentation product to form a plant treatment product. One or more alternative or additional embodiments of producing a plant treatment product comprise combining a substantially dry fermentation product (e.g., a fermentation product with or without a carrier) with a plant treatment component, preferably in a ratio of about 1:1 to about 1:100, adding the fermentation product to the plant treatment component for combination, or combining the plant treatment component with the fermentation product to form a plant treatment product.

[0159] The method for producing microbial fermentation products can include culturing one or more live and / or vigorous microorganisms (or microbial species or its strain or strain) under anaerobic (and optionally aerobic) conditions (e.g., in fermentation medium, etc., as known in the art and / or described herein) and / or under anaerobic (and optionally aerobic) conditions. Some embodiments can also include (intentionally) killing and / or inactivation (e.g., by cracking, such as by ultrasonic treatment, violent mixing or blending, heat inactivation, pH inactivation or killing, etc.), so that the fermentation product is substantially free of live and / or vigorous microorganisms. However, the fermentation product can include one or more (e.g., substantially all) cells and / or structural components of a microorganism. The fermentation product can also include at least one fermentation metabolite and / or fermentation medium (or its components).

[0160] Some embodiments include mixing (or reacting) one or more vitamins and / or minerals with the fermentation product. In particular, one or more vitamins and / or minerals may be combined or chelated with at least one of the metabolites of the fermentation product (e.g., such that the bioavailability of at least one metabolite is thereby increased).

[0161] At least one embodiment also includes a method for producing a carrier combined with a fermented product. The fermented product (substantially in liquid form) fluid can be applied to the carrier, for example, by spraying, pouring, dripping, etc., and / or the fermented product is combined with the carrier. The carrier can be or include a solid and / or substantially dry carrier, such as a soil carrier as described herein, optionally including one or more layered silicates. The carrier can also or alternatively be or include a liquid carrier, such as water or a water source or a water source, as described herein. The fermented product can be applied to the carrier or combined or mixed with the carrier so that the fermented product is dispersed in the carrier or in the entire carrier.

[0162] The fermentation product can be applied to the carrier in a ratio of up to, at least and / or about 1:1, about 1:1.5, about 1:2, about 1:2.5, about 1:3, about 1:3.5, about 1:4, about 1:5, about 1:6, about 1:7, about 1:8, about 1:9 or about 1:10 by weight, or vice versa. At least a portion of the fermentation product can physically and / or chemically react or mix and / or combine with the carrier. For example, at least a portion of the fermentation product can be adsorbed to the surface of the carrier and / or adsorbed below the surface of the carrier.

[0163] At least one embodiment may include a mixed carrier and / or a carrier in combination with a fermented product (e.g., before, after, and / or while the fermented product is applied to the carrier). The carrier and / or the carrier in combination with the fermented product can be mixed in any suitable container or on any suitable surface. For example, the carrier can be mixed by rotation (e.g., in a drum or barrel), by shaking (e.g., on a tray or container or therein), by stirring (e.g., on a tray or container or therein), etc. In addition, the carrier can be mixed at any suitable speed. Regardless of the specific type, container, surface, etc. of mixing, mixing can be measured according to rotation, rotation, and / or reciprocating motion (rpm) per minute. For example, the carrier can be mixed at a speed of about 1-500rpm, about 5-300rpm, about 10-200rpm, about 15-100rpm, about 20-60rpm, about 30-50rpm, or any range therebetween. In certain embodiments, a suitable mixing speed can ensure that the carrier, the carrier combined with the fermented product, and / or other combination products are appropriately and / or optimally processed. For example, mixing speeds above a certain threshold can reduce the size and / or uniformity of the product particles to below an appropriate and / or optimal level. Similarly, mixing speeds below a certain threshold can inhibit adequate or successful application or coating of the fermented product around or near the carrier, and / or can cause product agglomeration, resulting in inappropriate and / or substandard size and / or uniformity of the product particles. In any case, the effects of improper mixing can include reduced stability and / or activity of the product.

[0164] Certain embodiments may include applying air or an air flow. The air or air flow may be applied (i) while mixing the carrier and / or the carrier combined with the fermentation product (e.g., before, after, and / or while applying the fermentation product to the carrier), (ii) for a predetermined or defined period of time (e.g., between about 6-120 hours, between about 12-96 hours, between about 12-120 hours, between about 48-60 hours, etc.), and / or (iii) until the carrier combined with the fermentation product reaches a suitable moisture content, as described herein. In addition, in certain embodiments, the air or air flow may be applied at a rate of greater than or equal to about 25 m / s. 3 / minute, up to about 200m 3 / minute, between about 25m3 / min and about 200m 3 / minute, between about 40m 3 / min and about 150m 3 / minute, between about 50m 3 / min and about 100m 3 / minute, or about 60m 3 / minute and about 75m 3 The airflow is applied at a rate of about 68 m / min. 3 / minute rate of application. In some embodiments, the appropriate temperature can ensure that the mixture is dried to a suitable moisture content within a suitable time, thereby reducing, inhibiting and / or substantially preventing and / or avoiding product agglomeration or agglomeration, microbial contamination and / or growth, etc.

[0165] In at least one embodiment, the method includes maintaining the carrier, the mixed fermentation product and the carrier, and / or the carrier combined with the fermentation product at a suitable reaction temperature (e.g., less than about 60°C, less than about 58°C, less than about 56°C, less than about 55°C, less than about 52°C, less than about 50°C, less than about 48°C, less than about 45°C, less than about 42°C, less than about 40°C, less than about 39°C, less than about 38°C, less than about 37°C, less than about 35°C, less than about 32°C, less than about 30°C, less than about 25°C, less than about 20°C, etc., and / or greater than about 5°C, greater than about 10°C, greater than about 15°C, or greater than about 20°C) during the reaction and / or combination process. In some embodiments, the suitable reaction temperature can ensure that the reaction occurs at an optimal speed / rate, the reaction product is dried (at a suitable rate) to a suitable moisture content, etc. In addition, the method can include maintaining the reaction product and / or the carrier combined with the fermentation product at a suitable maintenance and / or storage temperature (e.g., below about 42°C, below about 40°C, below about 39°C, below about 38°C, below about 37°C, below about 35°C, below about 32°C, below about 30°C, below about 28°C, below about 25°C, below about 20°C, below about 15°C, or below about 10°C, below about 5°C, below about 2°C, etc., and / or above about 0°C, above about 2°C, above about 5°C, above about 10°C, or above about 15°C, etc.) after or near completion of the reaction and / or combination process. In some embodiments, a suitable maintenance temperature can improve, enhance and / or maintain the stability, lifespan and / or composition of the reaction product and / or the carrier combined with the fermentation product (i.e., avoid, reduce and / or inhibit its decomposition).

[0166] In addition, in one or more embodiments, the above parameters (e.g., mixing, application, air, temperature, etc.) can cause and / or enhance the binding of the fermented product to the carrier. For example, these parameters can cause and / or enhance the adsorption of the fermented product on the surface of the carrier, the absorption of the fermented product under the surface of the carrier, and / or the drying of the fermented product on or in the carrier. Thus, in some embodiments, the fermented product can be dry-bound to the carrier or become dry-bound to the carrier.

[0167] In at least one embodiment, the method may further include maintaining the carrier combined with the fermentation product at a suitable reaction pH of between about 2 and 10, preferably between about 2 and 8, more preferably between about 2 and 6, still more preferably between about 2 and 5, still more preferably between about 2 and 4, still more preferably between about 2 and 3, still more preferably between about 3 and 10, still more preferably between about 3 and 8, still more preferably between about 3 and 6, still more preferably between about 3 and 5, still more preferably between about 3 and 4, still more preferably between about 4 and 10, still more preferably between about 4 and 8, still more preferably between about 4 and 6, still more preferably between about 4 and 5, etc. during the reaction and / or combination process. In some embodiments, the suitable pH can ensure and / or enhance the chemical reaction. The method may also include maintaining the carrier associated with the fermentation product at a suitable maintenance pH of between about 2 and 10, preferably between about 2 and 8, more preferably between about 2 and 6, still more preferably between about 2 and 5, still more preferably between about 2 and 4, still more preferably between about 2 and 3, still more preferably between about 3 and 10, still more preferably between about 3 and 8, still more preferably between about 3 and 6, still more preferably between about 3 and 5, still more preferably between about 3 and 4, still more preferably between about 4 and 10, still more preferably between about 4 and 8, still more preferably between about 4 and 6, still more preferably between about 4 and 5, etc. after or near completion of the reaction and / or binding process. In some embodiments, a suitable maintenance pH can improve, enhance and / or maintain the stability, lifespan and / or composition of the reaction product and / or the carrier associated with the fermentation product (i.e., avoid, reduce and / or inhibit its decomposition). In addition, a suitable maintenance pH can inhibit microbial contamination and / or growth on or in the product (e.g., particularly at lower pH). In at least one embodiment, the reaction can have a pH-lowering effect (eg, on the carrier and / or a mixture of carrier and fermentation product).

[0168] Some embodiments include mixing one or more vitamins and / or minerals with a carrier that is combined with a fermented product (or a carrier that applies a fermented product) (e.g., as described above or otherwise mixed). As described above, one or more vitamins and / or minerals can be combined or chelated with at least one metabolite of the fermented product (e.g., so that the bioavailability of at least one metabolite is increased). Vitamins and / or minerals can also enhance the nutritional value of the product. As described herein, embodiments can also include mixing a carrier combined with a fermented product with one or more additional components (e.g., plant extracts, etc.) (e.g., as described above or otherwise mixed).

[0169] Some embodiments include methods for making plant treatment products. The method may include mixing plant treatment components with microbial fermentation products to form a combined plant treatment product. In some embodiments, the plant treatment components are mixed with liquid microbial fermentation products in a mixing tank before product distribution. In one or more additional or alternative embodiments, the plant treatment components and liquid microbial fermentation products are formulated together. Additional ingredients can be mixed with the plant treatment components and the microbial fermentation products. Additional ingredients can include stabilizers, emulsifiers and / or water or organic mineral oil matrices. In some embodiments, the plant treatment components are mixed with dry or substantially dry microbial fermentation products (or carriers combined with fermentation products). The plant treatment components and the microbial fermentation products can be ground to the same or substantially the same particle size. The plant treatment product obtained by mixing the plant treatment components with the microbial fermentation product can be water-soluble, thereby forming a stable suspension in water. Embodiments can also include packaging the plant treatment product.

[0170] It should be understood that certain embodiments of the present disclosure may include methods for enhancing crop health. The method may include applying an effective amount of a crop protection product to the plant so as to improve one or more health indicators of a plant or plant population (e.g., compared to a control group). The one or more health indicators may be selected from the group consisting of: wilting, coloring, yield, size and / or weight, life span and / or mortality, overall health and appearance, etc. The step of applying may include spraying and / or distributing a mixture of a plant treatment component and a microbial fermentation product on or near the plant so that the plant ingests an effective amount of the plant treatment product. The plant treatment component and the microbial fermentation product may also be applied separately.

[0171] In some embodiments, a method comprises applying an effective amount of a crop protection product to seeds (e.g., a group of seeds intended for sowing) to improve one or more health indicators of the germinating seeds and / or later germinating plants or plant populations (e.g., compared to a control group). The one or more health indicators can be selected from the group consisting of: stronger germination, wilting, coloring, yield, size and / or weight, lifespan and / or mortality, overall health and appearance, etc.

[0172] The step of applying can include spraying and / or distributing the plant treatment product (e.g., comprising a plant treatment component and a microbial fermentation product or a mixture thereof) on the plant or near the plant, such as on the soil, so that the plant takes in an effective amount of the plant treatment product from the soil. The plant treatment component and the microbial fermentation product can also be applied separately. Soil treatment using the disclosed plant treatment product can be carried out before planting, before germination, after germination, and at any time during the life of the plant.

[0173] Additional features and advantages of the exemplary embodiments of the present disclosure will be set forth in the following description and will become apparent in part from the description, or may be understood by practicing such exemplary embodiments. The features and advantages of these embodiments may be realized and obtained by the instruments and combinations specifically noted in the appended claims. These and other features will become more apparent from the following description and the appended claims, or may be understood by practicing these exemplary embodiments as described below.

[0174] Exemplary Experimental Results

[0175] Various plant treatment products comprising: (i) a selected plant treatment component (e.g., pesticide, fungicide, herbicide) and (ii) one or more microbial fermentation product formulations (Compositions A, B, C and Compositions) were tested on (1) rice (Oryza sativa L.) infected with rice sheath blight (Rhizoctonia solani), (2) soybean (Solanum lycopersicum) infected with soybean rust (Phakopsora pachyrhizi), (3) wheat (Triticum aestivum) infected with stripe rust (Puccinia striatum), (4) corn (Zea mays) infected with gray leaf spot (Ceratitis maydis), (5) creeping bentgrass infected with dollar spot (Sclerotina homoeocarpa), and (6) glyphosate-tolerant Palmer amaranth (Pendula officinalis) weeds and compared to controls, including the plant treatment component alone.

[0176] The microbial fermentation product formulation designated as composition A, B, C and D is consistent with the microbial fermentation product described in the present disclosure.Each of composition A, B, C and D comprises the cell material of the microorganism of fermentation culture and the anaerobic metabolites produced by the microorganism of culture.Specifically, each of composition A, B, C, D comprises the complete culture lysate of lactobacillus fermentation suspension culture, and comprises the cell material of (i) fermentation medium component, (ii) cracked lactobacillus bacteria and (iii) anaerobic metabolites produced by the lactobacillus bacteria.The difference between composition A, B, C, D is usually in the concentration of various amino acids, minerals and / or organic acids added to the fermentation product.Each (substantially or completely) in the fermentation product formulation (or composition) does not contain the living microorganism from the fermentation culture.Plant treatment product is applied in liquid form, but is not combined or coated in urea granules or pills or other fertilizers based on urea-n nitrogen (for example, with solid, granule or pill form) around. In fact, each of the plant treatment products is substantially free of (granular or pelletized) urea and other urea-n based fertilizers (eg, in solid, granular or pelletized form).

[0177] To test the effect of the plant treatment products according to the invention on sheath blight in rice caused by Rhizoctonia solani, the corresponding plant treatment products (fungicide + composition A, composition B or composition A + B) or the fungicide (alone) were applied to rice plants three times under field conditions at a rate of 500 ml / ha: 1) at the 4-5 leaf stage / at the beginning of tillering, 2) 10-14 days before Rhizoctonia solani inoculation, and 3) at the beginning of the booting stage. The fungicides tested were (azoxystrobin) at rates of 0.7 liters / ha (100%) and 0.35 liters / ha (50%). Plants were given a disease score of 0-9, with 0 indicating that the plant had no disease and 9 indicating that the plant showed severe disease symptoms (i.e., dead leaves). See Tables 1 to 3. Surprisingly, at 100% fungicide rate and 50% fungicide rate, each plant treatment product achieved a statistically significant improvement in disease control. Therefore, the plant treatment products of the present invention can improve the fungicidal activity or the effectiveness of fungicide treatments.

[0178]

[0179] Table 1 Disease scores of rice under field conditions (root rot infection)

[0180]

[0181] Table 2 Disease scores of rice under field conditions (root rot infection)

[0182]

[0183] Table 3 Disease scores of rice under field conditions (root rot infection)

[0184] To test the effect of the plant treatment product of the invention on (Asian) soybean rust caused by Phakopsora pachyrhizi in soybean and the corresponding soybean yield, the plant treatment product (composition A + fungicide) or the fungicide component (alone) was applied to soybean plants under field conditions. Composition A was applied at an application rate of 0.5 l / ha at the V4 stage, and the plant treatment component, fungicide, and fungicide were applied again at 0.3 kg / ha in R1, R2, R3 and R3 / R4. (Benzotrifloxacin with azoxystrobin). The results were compared with an untreated control group. See Tables 4 and 5. Surprisingly, Composition A applied together with the fungicide reduced disease severity (%) and increased yield (kg / hectare) in soybeans compared to the fungicide alone. Thus, the plant treatment product of the present invention can improve the fungicidal activity or the effect of the fungicide treatment and increase the yield after the fungicide treatment. For fungicides Similar results were observed for prothioconazole (trifloxystrobin) (data not shown).

[0185] Untreated control group Fungicides Fungicide plus composition A 20.9 12.7 11.4 - -39.2% -45.5%

[0186] Table 4 Disease severity (%) in soybean under field conditions (Phakora pachyrhizi infection)

[0187] Untreated control group Fungicides Fungicide plus composition A 2839a 3021ab 3270b - +6.4% +15.2%

[0188] Table 5 Soybean yield under field conditions (kg / hectare) (Psora pachyrhizi infection)

[0189] In order to test the effect of the plant treatment product of the present invention on stripe rust caused by Puccinia striiformis in wheat and the corresponding wheat yield, the plant treatment product (composition A + fungicide) or the fungicide component (alone) was applied to wheat plants under field conditions. At the 4-5 leaf stage of the second node stage, composition A was applied at a rate of 0.5 liters / hectare and the composition A was mixed with the plant treatment component fungicide. (Azoxystrobin containing propiconazole) was combined at a rate of 1 liter / hectare in the early booting stage. The results were compared with the untreated control group. See Tables 6 to 7. Surprisingly, Composition A applied together with the fungicide reduced the degree of disease in wheat (%) and increased the yield of wheat (kg / hectare) compared to the use of the fungicide alone. Therefore, the plant treatment product of the present invention can improve the fungicidal activity or the effect of the fungicide treatment and increase the yield after the fungicide treatment.

[0190] Untreated control group Fungicides Fungicide plus composition A 52.2a 30.0b 25.6b - -42.5% -51%

[0191] Table 6 Disease severity of wheat under field conditions (%)

[0192] Untreated control group Fungicides Fungicide plus composition A 5596a 6543b 7256c - +16.9% +29.7%

[0193] Table 7 Wheat yield under field conditions (kg / hectare) (wheat stripe rust infection)

[0194] To test the effect of the plant treatment products of the present invention on corn caused by gray leaf spot pathogens and the corresponding corn yield, the plant treatment products (composition A + composition B + fungicide) or the fungicide component (alone) were applied to corn under field conditions. The plant treatment component fungicide was applied at 7 fl oz / acre of composition A, 7 fl oz / acre of composition B and 5.5 fl oz / acre of the plant treatment component. The plant treatment product was applied at a rate of 5.5 fl oz / acre (azoxystrobin containing propiconazole) and the plant treatment product was mixed with the plant treatment component fungicide applied separately at a rate of 5.5 fl oz / acre (Azoxystrobin containing propiconazole) was compared. The results were compared with the untreated control group. See Table 8. Surprisingly, the combination of composition A and composition B with the fungicide reduced the degree of susceptibility of corn (%) compared to the fungicide applied alone. Therefore, the plant treatment product of the present invention can improve the fungicidal activity or the effect of the fungicide treatment.

[0195] Untreated control group Fungicides Fungicide plus combination A+B 14.3a 4.8b 3.9b - -66.4% -72.7%

[0196] Table 8 Disease severity of corn under field conditions (%) (infection with gray leaf spot pathogen)

[0197] In order to test the effect of the plant treatment product of the present invention on the survival of weeds in the Palmer amaranth (Pamer pigweed) plants tolerant to herbicides, the plant treatment product (composition C+herbicide) or the herbicide component (alone) was applied to the weeds under greenhouse conditions. The plant treatment product (diluted with water and applied to Palmer amaranth about 15 cm high, glyphosate-resistant in a fine mist spray form at a delivery rate of 260 liters / hectare) was applied at a ratio of 1 liter / hectare composition C and 1.27 kg / hectare active herbicide component glyphosate, and the plant treatment product was compared with the herbicide applied alone. The dry branch mass and dry root mass were measured two weeks after spraying. The results were compared with the untreated control group and the herbicide applied alone. Referring to Table 9 and Table 10. Surprisingly, in the herbicide-tolerant plants, the composition C containing the herbicide reduced the weight of the buds and roots compared with the herbicide alone. Therefore, the plant treatment product of the present invention can enhance the herbicide sensitivity of the herbicide-tolerant plants.

[0198] Untreated control group herbicide Herbicide plus combination C 18.9 / 5.71 15.0 / 5.31 8.73 / 3.37 - -20.6 / -7.01% -53.8 / -41.0%

[0199] Table 9 Fresh weight / dry weight of Amaranthus palmatus shoots per plant under greenhouse conditions

[0200] Untreated control group herbicide Herbicide plus combination C 9.65 / 1.30 4.70 / 0.768 2.37 / 0.416 - -51.3 / -40.9% -75.4 / -68.0%

[0201] Table 10 Fresh weight / dry weight of Amaranthus palmatus roots per plant under greenhouse conditions

[0202] To test the effectiveness of the plant treatment products of the present invention against dollar spot (Sclerotina homoeocarpa) infection in creeping bentgrass, the plant treatment products (Composition D + fungicide) or the fungicide component (alone) were applied to creeping bentgrass under greenhouse conditions. Composition D was applied at a rate of 500 ml / ha with a reduced rate of 2.6 oz / 1000 ft2 of the broad spectrum fungicide Daconil (thiophanate-methyl) was applied to creeping bentgrass and compared to the fungicide alone applied at a full rate of 3.25 oz / 1000 sq. ft. The results were compared to an untreated control group. See Table 11. Surprisingly, Composition D, with a reduced application of fungicide, resulted in a reduced susceptibility level (%) and comparable to that of the full rate of fungicide applied alone. Thus, the plant treatment product of the present invention can achieve a complete fungicidal benefit by reducing the application or use of chemical fungicides.

[0203]

[0204] Table 11 Disease susceptibility of creeping bentgrass (infected with dollar spot) under greenhouse conditions (%)

[0205] The statistical significance of the results is indicated by a letter (or letter combination) indicator after each data number. Numbers in a row that do not share at least one letter indicator have a statistically significant difference. In other words, the difference between any two numbers in the same row is statistically significant; if two numbers do not have at least one letter indicator in common, it is calculated using Fisher's protected LSD test (or least significant difference) (P < 0.05).

[0206] in conclusion

[0207] Without being bound by any theory, the beneficial effects of the plant treatment products of the present disclosure, including but not limited to reducing disease / infection, increasing yield and enhancing herbicide sensitivity, may be at least partially attributed to the molecular and / or biochemical effects of the microbial fermentation products on the treated plants. As described herein, various plant treatment components can have beneficial effects on the plants to which they are applied. For example, chemical fungicides can reduce diseases caused by fungal infections, thereby increasing yield by reducing the loss of plant biomass and yield. However, chemical fungicides may also cause significant (biological) stress to plants. For example, the application of chemical fungicides may result in changes or illegal changes in plant gene expression and other molecular and / or biochemical reactions. The embodiments of the present disclosure can provide beneficial effects by reducing certain negative or harmful effects of plant treatment components on plants. For example, the embodiments of the present disclosure have been shown to beneficially change the gene expression (spectrum) of genes related to pathogenesis and oxidative stress (e.g., superoxide dismutase). Therefore, plants applying the plant treatment products of the present invention can obtain the benefits of chemical plant treatment components, but reduce negative or harmful (side) effects, such as oxidative stress. Furthermore, the fermented products of the present disclosure may act synergistically with plant treatment components to provide beneficial pesticidal and plant growth properties.

[0208] Without departing from the spirit and scope of the present invention as defined by the claims, various changes and / or modifications may be made to the inventive features described herein and to the additional applications of the principles described herein, which changes and / or modifications are conceivable to the relevant art and to those skilled in the art who possess the present disclosure. Therefore, although various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. Although many methods and components similar or equivalent to those described herein can be used to practice embodiments of the present disclosure, only certain components and methods are described herein.

[0209] The disclosure of certain features relative to a specific embodiment of the present disclosure should not be interpreted as limiting the application or inclusion of the features to the specific embodiment. On the contrary, it should be understood that other embodiments may also include the features without departing from the scope of the present disclosure. Specifically, the products and / or methods according to certain embodiments of the present disclosure may include, incorporate or otherwise include the performance, features (e.g., components, components, members, elements, parts and / or parts), steps, etc. described in other embodiments disclosed and / or described herein. Therefore, the various features of certain embodiments may be compatible with other embodiments of the present disclosure, combined, included in other embodiments of the present disclosure and / or incorporated in other embodiments of the present disclosure.

[0210] Furthermore, unless a feature is described as requiring another feature to be combined with it, any feature herein may be combined with any other feature of the same or different embodiments disclosed herein. In addition, various well-known aspects of exemplary systems, methods, devices, etc. are not described in particular detail herein to avoid obscuring various aspects of the example embodiments. However, these aspects are also covered herein.

[0211] Without departing from the spirit or essential features of the present disclosure, the present disclosure may be embodied in other specific forms. The described embodiments are considered to be illustrative and not restrictive in all respects. Therefore, the scope of the present invention is indicated by the appended claims rather than by the preceding description. Although certain embodiments and details are included herein and in the appended disclosure for the purpose of illustrating the embodiments of the present disclosure, it is obvious to those skilled in the art that various changes may be made to the methods, products, devices and equipment disclosed herein without departing from the scope of the present disclosure or the appended claims. All changes within the meaning and scope of the equivalents of the claims are included within the scope of the claims.

Claims

1. A plant treatment product comprising: Fungicides; as well as A bacterial fermentation product comprising a whole culture lysate of a suspension culture of Lactobacillus, the whole culture lysate comprising: Fermentation medium; lysed Lactobacillus bacteria; and Anaerobic metabolites of the Lactobacillus bacteria.

2. The product according to claim 1, wherein the bacterial fermentation product is substantially free of living microorganisms.

3. The product according to claim 1, wherein the fungicide is selected from the group consisting of azoxystrobin, benzovinfluanid, prothioconazole, trifloxystrobin, propiconazole and thiophanate-methyl.

4. The product of claim 1, wherein the product is substantially free of: Urea and nitrogen-based fertilizers; and / or The cellular material of fungi.

5. The product according to claim 1, wherein the microbial fermentation product further comprises: cellular material of one or more additional microbial species and / or strains; as well as One or more anaerobic metabolic products of the one or more additional microbial species and / or strains.

6. The product according to claim 1, further comprising one or more additives selected from the group consisting of amino acids, peptides, hydrolyzed proteins, organic acids, carboxylic acids, carbohydrates, plant extracts, preferably seaweed extracts, preferably seaweed including Ascophyllum nodosum, lignin sulfonates, humic acid, macronutrients, subnutrients, micronutrients, trace minerals, chelated minerals, complex minerals, vitamins, wetting agents, dispersants and surfactants.

7. The product according to claim 1, further comprising a mixture of amino acids, minerals and organic acids.

8. The product according to claim 1, wherein the fungicide is in liquid form and the bacterial fermentation product is in liquid form, and wherein the fungicide and the bacterial fermentation product are optionally combined to form a liquid mixture.

9. Methods for treating plants, including: Apply to the plants: Fungicides; and A bacterial fermentation product comprising a whole culture lysate of a suspension culture of Lactobacillus, the whole culture lysate comprising: Fermentation medium; lysed Lactobacillus bacteria; and Anaerobic metabolites of the Lactobacillus bacteria.

10. The method of claim 9, wherein the fungicide and the bacterial fermentation product are co-applied to the plant.